Cardiovascular diseases and functional capacity : prevalence, secular changes and predictive value by Kattainen, Anna
Helsinki 2004
Anna Kattainen
CARDIOVASCULAR DISEASES AND
FUNCTIONAL CAPACITY
Prevalence, secular changes and predictive value
ACADEMIC DISSERTATION
To be presented with the permission of the Faculty
of Medicine of the University of Helsinki, for public examination
in the small auditorium of the Haartman Institute,
Haartmaninkatu 3, on June 21st, 2004, at 12 noon.
Department of Health and Functional Capacity
National Public Health Institute
Helsinki, Finland
and
Department of Public Health
University of Helsinki, Helsinki, Finland
Copyright National Public Health Institute
Julkaisija – Utgivare – Publisher
Kansanterveyslaitos (KTL)
Mannerheimintie 166
00300 Helsinki
Puh. vaihde (09) 47441, faksi (09) 4744 8408
Folkhälsoinstitutet
Mannerheimvägen 166
00300 Helsingfors
Tel. växel (09) 47441, fax (09) 4744 8408
National Public Health Institute
Mannerheimintie 166
FIN-00300 Helsinki, Finland
Telephone +358 9 47441, fax +358 9 4744 8408
Publications of the National Public Health Institute A7/2004
ISBN 951-740-443-3
ISSN 0359-3584
ISBN 951-740-444-1 (PDF version)
ISSN 1458-6290 (PDF version)
Hakapaino Oy
Helsinki 2004
Supervised by
Professor Arpo Aromaa, MD, PhD
and
Professor Antti Reunanen, MD, PhD
Department of Health and Functional Capacity
National Public Health Institute
Helsinki, Finland
Reviewed by
Docent Veikko Salomaa, MD, PhD
Department of Epidemiology and Health Promotion
National Public Health Institute, Helsinki, Finland
and
Docent Timo Strandberg, MD, PhD
Department of Medicine
Division of General Internal Medicine and Geriatrics
University of Helsinki, Helsinki, Finland
Opponent
Professor Marja Jylhä, MD, PhD
Tampere School of Public Health
University of Tampere, Tampere, Finland

Contents
ABSTRACT .............................................................................................................................8
ABBREVIATIONS....................................................................................................................9
LIST OF ORIGINAL PUBLICATIONS ...................................................................................10
1 INTRODUCTION ...........................................................................................................11
2 REVIEW OF LITERATURE ...........................................................................................13
2.1 Cardiovascular diseases ......................................................................................13
2.1.1 Coronary heart disease ............................................................................13
2.1.1.1 Definition and measurement ....................................................13
2.1.1.2 Occurrence and secular changes.............................................14
2.1.2 Cerebrovascular disorders ........................................................................17
2.1.2.1 Definition and measurement ....................................................17
2.1.2.2 Occurrence and secular changes.............................................17
2.1.3 Heart failure ..............................................................................................18
2.1.3.1 Definition and measurement ....................................................18
2.1.3.2 Occurrence and secular changes.............................................19
2.1.4 Hypertension ............................................................................................20
2.1.4.1 Definition and measurement ....................................................20
2.1.4.2 Occurrence and secular changes.............................................21
2.2 Disability and burden imposed on society ............................................................21
2.2.1 Definition and measurement of disability in epidemiological studies ........21
2.2.2 Secular changes in disability ....................................................................23
2.2.3 Chronic morbidity and disability ................................................................24
2.2.3.1 Cardiovascular diseases and disability ....................................25
2.2.4 Coronary heart disease and disability burden ..........................................26
2.2.5 Disability as a predictor of mortality ..........................................................26
3 AIMS OF THE STUDY ..................................................................................................27
4 MATERIALS AND METHODS .......................................................................................28
4.1 Health examination surveys .................................................................................28
4.1.1 The Mini-Finland Health Survey ...............................................................28
4.1.2 The FINRISK-97 Senior Survey ................................................................29
4.1.3 The Health 2000 Survey ...........................................................................29
4.2 Study populations ................................................................................................30
4.3 Study variables and definitions ............................................................................31
4.3.1 Coronary heart disease ............................................................................31
4.3.1.1 Mortality from coronary heart disease......................................32
4.3.2 Other cardiovascular diseases ..................................................................32
4.3.2.1 Self-reported other cardiovascular conditions ..........................32
4.3.2.2 Clinical diagnoses of other cardiovascular conditions ..............32
4.3.2.3 Any cardiovascular disease, any cardiovascular disease
except hypertension and any heart disease ............................32
4.3.3 ECG findings .............................................................................................33
4.3.4 Other chronic diseases .............................................................................33
4.3.5 Disability ...................................................................................................33
4.3.6 Cognitive impairment ................................................................................34
4.3.7 Obesity ......................................................................................................34
4.3.8 Blood pressure ..........................................................................................34
4.3.9 Other variables .........................................................................................34
4.4 Statistical methods ...............................................................................................35
4.4.1 Means and prevalences ............................................................................35
4.4.2 Mortality ....................................................................................................35
4.4.3 Impact of cardiovascular diseases and other chronic diseases
on disability ...............................................................................................35
4.4.4 Assessment of the impact of the changes in coronary heart disease
on disability ...............................................................................................36
4.4.5 Statistical software ....................................................................................36
5 RESULTS ......................................................................................................................37
5.1 Secular changes in the prevalence of cardiovascular diseases ...........................37
5.2 Cardiovascular diseases as determinants of disability .........................................39
5.3 Secular changes in CHD-related disability burden in Finland
from 1978–1980 to 2000–2001 ............................................................................41
5.3.1 Prevalence of disability .............................................................................41
5.3.2 Contribution of coronary heart disease to disability ..................................41
5.3.3 Contribution of coronary heart disease to the decline in disability
from 1978–1980 to 2000–2001 .................................................................43
5.4 Disability as a predictor of mortality in persons with and without coronary
heart disease .......................................................................................................43
6 DISCUSSION ................................................................................................................45
6.1 Population ............................................................................................................45
6.2 Methods ...............................................................................................................46
6.3 Prevalence of cardiovascular diseases (studies I and III) ....................................47
6.3.1 Coronary heart disease ............................................................................47
6.3.2 Hypertension ............................................................................................50
6.3.3 Heart failure ..............................................................................................50
6.3.4 Cerebrovascular disease ..........................................................................51
6.4 Cardiovascular diseases as determinants of disability (Studies II and III) ...........51
6.5 Secular changes in coronary heart disease related disability burden
(Study III) .............................................................................................................53
6.6 Disability as a predictor of mortality (Study IV) ....................................................55
6.7 Implications for future research ............................................................................57
SUMMARY AND CONCLUSIONS ........................................................................................59
ACKNOWLEDGMENTS ........................................................................................................60
REFERENCES .....................................................................................................................61
8ABSTRACT
The main objective of this study was to examine 20-year time trends in the
disability burden caused by coronary heart disease (CHD) in Finland. To do this,
time trends in the prevalence of CHD and disability were examined, and the
proportion of change in overall disability in Finland due to changes in CHD
prevalence and CHD-related disability were estimated. The impact of different
cardiovascular diseases on disability and the need for help among elderly Finns
was examined, as was the importance of disability as a predictor of mortality in
men and women suffering from CHD.
Data from three population-based health examination surveys with high
participation rates (Mini-Finland Health Survey in 1978–1980, FINRISK-97
Senior Survey in 1997 and Health 2000 Survey in 2000–2001) were used. The
Mini-Finland Health Survey and Health 2000 Survey represented the Finnish
population aged 30 years and over, and the FINRISK-97 Senior Survey included
persons aged 65–74 years from two areas of Finland. In the substudies of this
thesis, persons aged 45 years or more were included. Mortality of participants in
the Mini-Finland Health Survey was followed until the end of 1994. The main
statistical methods used in the studies were logistic regression analysis and the
Cox proportional hazards model.
Cardiovascular diseases (in particular cerebrovascular diseases and in women, also
myocardial infarction and heart failure) were strongly associated with disability in
persons aged 65–74 years. These diseases were also quite common, and thus they
accounted for a third of population level disability in men and a fourth in women
in this age group. Disability increased mortality in men regardless of the presence
of CHD, and in women without CHD. Prevalence of CHD has decreased among
middle-aged Finns and increased among men and women aged 75 years or over
from 1978–1980 to 2000–2001. Prevalence of disability has decreased in men and
women under the age of 75 years. The decrease was evident in men with and
without CHD and in women without CHD, but no significant decline was observed
in women with CHD. Up to 25% of the decrease in disability in Finland during the
past 20 years was estimated to be due to CHD-related changes. In men aged 75
years or more and in women aged 65 or more, however, CHD-related disability has
increased rather than decreased, although overall disability has slightly decreased.
The burden of CHD has not disappeared but shifted to older age groups. Due to the
growing number of elderly people with CHD, disability associated with the disease
is likely to become a growing social and health burden to the community. In
particular, elderly women with myocardial infarction need more attention to
improve their health and functional capacity, and to prevent the burden caused by
CHD and its consequences from increasing.
9ABBREVIATIONS
ADL activities of daily living
AP angina pectoris
BMI weight/height2, kg/m2
BP blood pressure
CHD coronary heart disease
CI confidence interval
CVD cardiovascular disease
DPB diastolic blood pressure
ECG electrocardiogram
IADL instrumental activities of daily living
ICD International Classification of Diseases
ICF International Classification of Functioning, Disability and Health
ICIDH International Classification of Impairments, Disabilities and Handicaps
MI myocardial infarction
MMSE Mini Mental State Examination
N number
NYHA New York Heart Association
OECD Organization for Economic Co-operation and Development
OR odds ratio
RR relative risk
SBP systolic blood pressure
WHO World Health Organization
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1 INTRODUCTION
Cardiovascular diseases (CVD) are important causes of illness, disability, and
death (Wenger 1988; Murray et al. 1996; Sans et al. 1997). Although mortality
from CVD has decreased around 60% during the last 20 years in middle-aged
Finns, in 2002 40% of all deaths in men and 45% in women in Finland were
caused by CVD (Statistics Finland 2003a). The decrease in mortality has been
greatest among the middle-aged, but there has also been a marked decrease in the
elderly (Kesteloot et al. 2002; Martelin et al. 2003; Statistics Finland 2003a).
Incidences of acute coronary heart disease (CHD) events and stroke in the middle-
aged Finnish population have decreased, but to a lesser extent than mortality
(Numminen et al. 1996; Salomaa et al. 1996a; Statistics Finland 1996; Salomaa et
al. 2003). Incidence of stroke has also decreased in the elderly (Numminen et al.
1996), but except for some limited information based on registers collected for
administrative purposes, there are no valid data on how the incidence of acute
CHD events in the elderly has changed in Finland (National Public Health
Institute; Salomaa et al. 1996b; Salomaa et al. 1996c). Data concerning secular
changes in the incidence and prevalence of heart failure are scarce.
The dramatic decrease in mortality, over 70% during the last 25 years (Statistics
Finland 1998; Statistics Finland 2003a), and the marked decrease in the incidence
of acute CHD events among middle-aged Finns, may tempt one to draw the
conclusion that the prevalence of CHD has also decreased, and that these
reductions have occurred also among elderly persons. However, the annual number
of hospital treatment days with CHD diagnoses increased rather than decreased
among elderly persons in the 1980s (Pyörälä et al. 1994). An important aim of this
study was to clarify secular changes in the prevalence of CHD and also other
CVDs among elderly persons.
The population in Finland, as in many other developed countries, is aging (World
Population Ageing: 1950–2050 2001). The number of individuals aged 65 years or
more will increase by over 70% from 2003 to 2030 (Statistics Finland 2003b). The
incidence and prevalence of CVD increase markedly with age, and so does the
prevalence of disability (Guralnik et al. 1993; Andersen-Ranberg et al. 1999). It
may therefore be assumed that the burden on the health-care system resulting from
CVD and related disability will increase as the population ages. The burden of
CVD on society depends on the incidence and prevalence of CVD in each age
group, the degree of disability caused by CVD, and the age structure of the
population. In order to assess the future burden to health care, social, and
rehabilitation services due to CVD, it is important to examine how the functional
ability of persons suffering from these diseases has changed, and to study the
secular changes in prevalence.
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This thesis is based on three cross-sectional population-based health examination
surveys conducted in Finland from 1978 to 1980, in 1997, and from 2000 to 2001,
including follow-up results of the first survey. The aim of these surveys was to
estimate the prevalence of chronic diseases, activity limitations, and the need for
care in the Finnish population. This thesis considers various CVDs, but
concentrates on CHD. Secular changes in the prevalence of various CVDs and in
the prevalence of disability among persons suffering from CHD are described. The
impact of specific CVDs on activity limitations and the need for help in elderly
Finns is examined, as well as the importance of disability as a predictor of
mortality in persons with and without CHD. Secondary objectives were to reveal
possible age group and gender differences.
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2 REVIEW OF LITERATURE
2.1 Cardiovascular diseases
CVDs have for a long time been among the major public health concerns in
Finland. Although CVD mortality has declined considerably (Martelin et al. 2003),
they still account for over 40% of all deaths in Finland (Statistics Finland 2003a),
as in most Western countries. In eastern European countries this percentage is much
higher (Kesteloot et al. 2002). In 2002, 9585 deaths in men and 11460 deaths in
women in Finland were due to these diseases (Statistics Finland 2003a). The most
common CVDs are hypertension, CHD, heart failure, and cerebrovascular dis-
orders. Data on the prevalence of chronic CVD, especially on changes in CVD
prevalence in the elderly in Finland, is limited. According to the basic report of the
recent Health 2000 Survey, the prevalence of CHD has declined among working-
aged Finns during the past 20 years, but among persons aged 65 years or over the
decline has been smaller (Aromaa et al. 2002). It is uncertain how the burden of
CVD and related disability has developed among the elderly.
2.1.1 Coronary heart disease
2.1.1.1 Definition and measurement
The term CHD refers to the consequences of oxygen deficiency in the myocardium
caused by the decrease or complete interruption of the blood supply, generally
originating from reduced blood flow from coronary arteries and usually caused by
atherosclerotic changes (Miles et al. 1990). Sudden death, myocardial infarction
(MI), and angina pectoris (AP) are the most common manifestations of the disease.
Silent ischaemia and silent electrocardiogram (ECG) changes are also mani-
festations of CHD.
In population studies, the prevalence of previous MI and AP has commonly been
assessed by interview questions relating to known diseases, clinical examination
and physician diagnosis, or by a standardized World Health Organization (WHO)
questionnaire (Rose et al. 1968; Reunanen et al. 1983). Resting ECG is the most
common objective measurement of CHD applied in population studies. The
changes related to CHD in ECG are usually coded according to the Minnesota
code suggested by the WHO (Rose et al. 1968). National registers of hospital
discharge diagnosis and causes of death on death certificates have also commonly
been utilized to assess the occurrence of CHD (Joensuu 1989; Mähönen et al.
1999; Mähönen et al. 2000). In MI registers, the events are classified on the basis
of symptoms, cardiac enzymes, serial Minnesota coding of ECGs, and in fatal
cases autopsy findings and history of CHD (Romo 1972; Tuomilehto et al. 1992;
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Salomaa et al. 2003). The serious outcomes of CHD (acute MI and fatal CHD)
used in MI registers and in the WHO MONICA Project (Tuomilehto et al. 1989;
Tunstall-Pedoe et al. 1994) can be defined more accurately than chronic CHD at
the population level. Procedures commonly used in clinical diagnostics, such as
exercise ECG and echocardiograph of the myocardium, have not been widely used
in epidemiology due to their cost and practical problems.
Some 20 to 30 years ago only standardized symptom questionnaires and resting
ECG-findings were thought to be acceptable methods in epidemiological studies of
CHD, and clinical diagnoses were thought to vary too much according to the
examining physician (Rose et al. 1968; Reunanen 1977; Reunanen et al. 1983).
Considering AP, good agreement between the WHO chest pain questionnaire and a
doctor’s independent diagnosis has been found among the elderly (Dewhurst et al.
1991).
Symptomatic CHD can be defined on the basis of disease history obtained from
examinees, AP symptoms, and ECG findings. Agreement between the results of a
health interview and a health examination has been shown to be good in the
detection of CVDs (Heliövaara et al. 1993). There was substantial agreement
between self-reported AP and MI in a questionnaire survey and data from medical
records among Finnish men and women (Haapanen et al. 1997). In addition, in a
British study the level of agreement between self-report and medical record was
substantial for doctor-diagnosed angina, and very high for doctor-diagnosed
ischaemic heart disease (angina or MI) in middle-aged and elderly men (Lampe et
al. 1999).
2.1.1.2 Occurrence and secular changes
Although CHD mortality has decreased around 70% during the last 25 years
among middle-aged Finns (Valkonen et al. 1993; Salomaa et al. 1996a; Statistics
Finland 1998; Salomaa et al. 2003; Statistics Finland 2003a), over a quarter of all
deaths in Finland were due to CHD in 2002 (Statistics Finland 2003a). The decrease
has been greatest among the middle-aged but there has also been a marked decrease
in the elderly (Pyörälä et al. 1994; Salomaa et al. 1996a; Statistics Finland 1996;
Kesteloot et al. 2002; Statistics Finland 2003a). In an international comparison,
CHD mortality among men in Finland was the highest in the world during the
1960s and early 1970s, while the figure for women was high but not the highest
(Pisa et al. 1982). The situation has improved, but male CHD mortality still
remains high compared to most other western countries (Uemura et al. 1988; Thom
et al. 1994; Sans et al. 1997; La Vecchia et al. 1998; Aromaa et al. 1999). The
mortality and incidence of acute CHD events has been much higher in eastern and
northeastern Finland than in southwestern Finland throughout the period for which
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reliable data are available (Romo et al. 1982; Joensuu 1989; Koskinen 1994;
Koskinen 1995; Salomaa et al. 1996b; Aromaa et al. 1999).
The incidence of acute CHD events in the middle-aged Finnish population has
decreased (Salomaa et al. 1992; Immonen-Räihä et al. 1996; Salomaa et al. 1996a;
Salomaa et al. 2003), but markedly less than mortality. Incidence of acute CHD
events has also declined in other western European countries, whereas this
development has not been as favourable in many eastern European countries,
where increasing incidence rates have even been reported (Tunstall-Pedoe et al.
1999). There are no reliable data for how the incidence of acute CHD events in the
elderly has changed in Finland. According to the national hospital-discharge
register, the use of hospital beds due to CHD markedly increased in persons
between 65 and 74 years of age, and particularly in persons aged 75 or more,
during the 1980s (Palomäki et al. 1993; Pyörälä et al. 1994). The increased
hospital use is largely a consequence of the increasing number of elderly
individuals and the sharp increase in the number of very old individuals. It is also
estimated that due to aging of the population, the increase in hospital treatment due
to CHD will increase by a third during the period from 1996 to 2010 (Luoto et al.
1999; Luoto et al. 2000).
A rough estimate of the prevalence of CHD can be obtained from the numbers
requiring drug treatment. In 2002, 102 985 men and 87 993 women were awarded
the right to reimbursements for CHD medication costs. Of those aged 65 years or
more, 22% of men had the right to special refunds in 2002, as did 15% of women
(Data in files of the Social Insurance Institution, Finland 2002). The incidence of
new rights to reimbursements for CHD medication costs has decreased during the
past years among middle-aged and elderly men and women, despite a temporary
increase in the late 1990s due to changes in the criteria for the right to the special
refund for lipid lowering drugs (Reunanen, personal communication).
The main reasons for the fall in morbidity and mortality from CHD are changes in
the known risk factors as well as improvements in treatment (Vartiainen et al.
1994b; Tunstall-Pedoe et al. 2000). The prevalence of high blood pressure (BP)
and high serum cholesterol concentration has declined in middle-aged men and
women. Smoking rates decreased among men from 1972 to 1997, after which they
increased. Smoking among women increased until 1992, then levelled off, but
increased again between 1997 and 2002 (Vartiainen et al. 1994a; Vartiainen et al.
2000; Laatikainen et al. 2003). The prevalence of daily smoking did not apparently
change among persons aged 65–74 years from 1985 to 2001 (Sulander et al. 2001).
However, the diet of the elderly population improved during the same time period
(Sulander et al. 2003).
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Survival after MI has improved during the past decades (Abrahamsson et al. 1998;
Salomaa et al. 1999). Significant advances have been made in the treatment of
CHD (Miettinen et al. 1999; Boersma et al. 2003). The supply of coronary
operations has increased during past ten years (Hetemaa et al. 2003). In 1997,
according to a Finnish study based on population-based MI registers carried out in
defined geographical areas, 25% of men and 16% of women aged 35–64 years
hospitalized with MI received a revascularization or a decision for revascu-
larization within the 28-day period after the onset of symptoms (Salomaa et al.
2003). Improved treatment may be leading to increased utilization of health
services at later stages in the disease process. It has been suggested that the
improved survival in acute coronary syndromes has resulted in a growing
population of patients with chronic cardiovascular conditions (Reitsma et al.
1999). On the other hand, bypass operations and coronary angioplasties have
helped to relieve symptoms and to improve the functional capacity of people with
serious CHD (The TIME investigators 2001; Henderson et al. 2003). Evidence of
the impact of revascularization on survival among patients with chronic CHD is
weaker (Blumenthal et al. 2000; The TIME investigators 2001; Henderson et al.
2003).
There are differences in the incidence, course, and clinical presentation of CHD
between men and women. In an international comparison, both nonfatal and fatal
CHD event-rates in women were low compared to those in men, particularly at
working-age (Tunstall-Pedoe 1996). Differences in major cardiovascular risk
factors explain part of the gender difference in CHD risk (Jousilahti et al. 1999).
Any initial manifestation of CHD occurs about 10 years later for women than for
men (Wenger 1998).
Acute MI and sudden death are the most usual manifestations in men, whereas AP
is the most common manifestation in women (Reunanen et al. 1983; Kannel et al.
1992; Wenger 1998). Diagnosis of CHD is more difficult in women than in men
(Kwok et al. 1999). Women with CHD report atypical symptoms more often than
men. Unrecognized MI is more common in women than in men (Lerner et al.
1986).
MI is more common in men than in women, and the gender differences in the
occurrence of AP are smaller (Lerner et al. 1986; Reunanen et al. 1991). It has
been shown that women with AP have a more favourable outlook than men with
similar symptoms (Reunanen et al. 1983; Murabito et al. 1993). Men with acute
MI are more likely to die prior to hospitalization, but in many studies women have
had higher hospital mortality rates than men (Wenger 1998; Wenger 2002). The
gender differences in mortality after acute MI have lessened, but not disappeared,
by controlling for older age and comorbidity (Wenger 2002). In Finland, however,
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in-hospital mortality has been similar for men and women (Salomaa et al. 2003).
Finnish men who were alive 28 days after their first MI were far more likely to
have a fatal recurrent event than women despite a comparable numbers of events
(Schreiner et al. 2001). There are gender differences in the care of CHD patients
(Swahn 1998). In Finland, men with acute MI received revascularizations and
thrombolytic treatment more often than women (Salomaa et al. 2003). Acute
coronary events occur more commonly in middle-aged men, but the more chronic
manifestations are more evenly distributed between men and women. With
advancing age, the risk of CHD equalises between the genders (Tunstall-Pedoe
1996). Due to changes in population age structure, the numbers of women with
CHD may even exceed that of men.
2.1.2 Cerebrovascular disorders
2.1.2.1 Definition and measurement
Cerebrovascular diseases include disorders of the arterial or venous circulatory
systems which produce or threaten to produce injury to the central nervous system.
The general term stroke describes the functional neurological injury (Plum et al.
1990).
In epidemiological studies, the diagnosis of stroke depends mainly on clinical data
and is often far from exact in mild cases. Stroke is a group of vascular diseases of
the central nervous system with a great variability in the clinical picture (Aho
1975). Stroke registers use the WHO definition: rapidly developing signs of focal
or global disturbance of cerebral function lasting over 24 hours (unless interrupted
by surgery or death), with no apparent nonvascular cause (Truelsen et al. 2003).
The increasing availability of imaging techniques may have improved the detection
of milder cerebrovascular disease cases in clinical settings but their use in
population studies is very limited.
2.1.2.2 Occurrence and secular changes
Mortality from cerebrovascular disorders has decreased by 50% among middle-
aged Finns during the past 20 years (Statistics Finland 2003a). Mortality from
stroke has also declined substantially among men and women aged 75–84 years. In
an international comparison, Finland is among the countries with middle-high
mortality from stroke (Thom 1993; Sans et al. 1997; Sarti et al. 2000).
The incidence of stroke in the middle-aged Finnish population has also decreased
(Sarti et al. 1994; Numminen et al. 1996; Tuomilehto et al. 1996; Sivenius et al.
2004), but markedly less than mortality. Incidence of stroke has decreased also in
the elderly (Numminen et al. 1996). The 28-day case-fatality of stroke in Finland
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has fallen from 1983 to 1992 (Immonen-Räihä et al. 1997). Results from the WHO
MONICA Project in nine countries suggest that changes in stroke mortality from
1982 to 1995 among persons aged 35–65 years are principally attributable to
changes in case-fatality rather than changes in event rates (Sarti et al. 2003). Thus,
it is important to also obtain information about nonfatal events when assessing the
burden of stroke in a community.
The number of in-patient days due to stroke increased during the 1980s and 1990s
because of the aging of the population. In particular, hospital bed days due to
stroke increased in women aged 75 years or over (Mähönen et al. 1994; Aromaa et
al. 1999). In 1994, half of all hospital bed days for treatment of stroke were for
persons aged 75 years or over, and 70% of these were for women (Salomaa et al.
1996c). Stroke has become a geriatric problem; both the relatively faster decline in
stroke mortality compared with incidence, suggesting improved survival, and the
increase in the elderly segment of the population have contributed to this. Thus, the
observed declining trend in stroke incidence has not diminished the need for stroke
care (Immonen-Räihä et al. 2003). Parallel results have been found also in
Denmark (Thorvaldsen et al. 1999). Results from the United States suggest an
increase in age-adjusted hospital admissions for stroke and also in self-reported
stroke prevalence (Fang et al. 2001; Muntner et al. 2002).
More widespread and improved control of hypertension has played a major role in
reducing cerebrovascular disease mortality. In Finland, two thirds of the fall in
mortality from stroke in men and half in women can be explained by population
changes in diastolic blood pressure (DBP), serum cholesterol concentration, and
smoking (Vartiainen et al. 1995). In a study including nine countries, it appeared
that variations in stroke trends between populations can be explained only in part
by changes in classic cardiovascular risk factors. The association between risk
factor trends and stroke trends were stronger for women than for men (Tolonen et
al. 2002).
2.1.3 Heart failure
2.1.3.1 Definition and measurement
Chronic heart failure is commonly defined as a pathophysiological state in which
an abnormality of cardiac function is responsible for the failure of the heart to
pump blood at a rate commensurate with the requirements of metabolizing tissues
(Remme et al. 2001). The European Society of Cardiology diagnostic criteria
require subjective symptoms at rest or during exercise, typically breathlessness,
fatigue or ankle swelling, supported by objective evidence of cardiac dysfunction
at rest. Response to treatment directed towards heart failure is considered
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desirable. Echocardiography is recommended as the most practical tool to
demonstrate cardiac dysfunction at rest (Remme et al. 2001).
Diagnosis of heart failure relies on clinical judgement based on history, physical
examination, and appropriate investigations. ECG, chest x-ray, possibly natriuretic
peptides, and echocardiography are the most important investigations. Several
different systems have been used in large population studies to define heart failure:
scores for clinical features determined from history and examination, chest
radiography, general practice monitoring, and drug prescription data (McKee et al.
1971; Carlson et al. 1985; Marantz et al. 1988; Mosterd et al. 1999b; Davis et al.
2000). The accuracy of diagnosis by clinical means alone is often inadequate
(Marantz et al. 1988; Remes et al. 1991). Echocardiography has been used in some
more recent studies (McDonagh et al. 1997; Cowie et al. 1999; Di Bari et al. 1999;
Davies et al. 2001). Different studies have used different levels of ejection fraction
to define systolic dysfunction (Davis et al. 2000). The lack of universal agreement
on a definition of  heart failure (Denolin et al. 1983), as well as the lack of a
golden standard to confirm the diagnosis, have both resulted in considerable
heterogeneity in the diagnosis of heart failure in epidemiological studies (Cowie et
al. 1997). This has made national and international comparisons of occurrence of
heart failure difficult.
2.1.3.2 Occurrence and secular changes
The most common causes of heart failure are CHD and hypertension. Heart failure
is fairly uncommon in middle age, but increases rapidly after the age 65 (Kannel et
al. 1991; Cowie et al. 1999). In eastern Finland, according to the Framingham
criteria, the annual age-adjusted incidence of heart failure was 4.1 per 1000 among
men and 1.6 per 1000 among women aged 45–74 years in the late 1980s (Remes et
al. 1992). The prevalence of heart failure in Finnish urban population aged 75–86
years was 8% in 1990 (Kupari et al. 1997).
There are several reports suggesting an increase in mortality and morbidity from
heart failure (Ghali et al. 1990; McMurray et al. 1993; Reitsma et al. 1996; Cowie
et al. 1997; Haan et al. 1997; Rich 1997; Cleland et al. 1999; Haldeman et al.
1999). There are also contradictory results (Murdoch et al. 1998; Stewart et al.
2001). The number of people entitled to special refunds for heart failure
medication costs has dropped sharply since the late 1970s in Finland (Data in files
of the Social Insurance Institution, Finland 2002). Part of this change can be
attributed to the reduced incidence of acute CHD events and more effective
treatment of hypertension (Aromaa et al. 1999). However, some of the change is
probably due to improvements in the diagnostics of heart failure. The better
availability of echocardiography since the early 1990s has probably decreased the
proportion of false positive heart failure diagnoses, which were fairly common in
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primary health care in Finland in the 1980s (Remes et al. 1991). The number of
patients with heart failure is expected to grow due to the aging of the population,
improved survival after MI, and greater awareness and improved diagnostic
techniques for the detection of heart failure (Eriksson 1995).
2.1.4 Hypertension
2.1.4.1 Definition and measurement
High BP is a well known risk factor for several common CVDs. It has been
suggested that the relationship between BP and adverse health effects is continuous
(Stamler et al. 1993; van den Hoogen et al. 2000). There has been debate, also
recently, whether the relationship between BP and mortality is linear or whether
there is a threshold below which there would be no reduction in the risk of diseases
associated with the increase in BP (Alderman 2000; Port et al. 2000). A Finnish
study showed that during a long follow-up, the relationship between systolic blood
pressure (SBP) and mortality was flat up to 140 mmHg and increased after that in
middle-aged men. Among men with other cardiovascular risk factors, however, the
risk of death increased progressively and linearly with SBP (Strandberg et al.
2001b). Thus, the association between BP and CVDs is modified by other cardio-
vascular risk factors. These results support the concept of total risk assessment
advocated in the current WHO-International Society of Hypertension guidelines
for management of hypertension (Guidelines Subcommittee 1999). The definition
of high BP has undergone many changes towards lower and lower threshold values
during the last decades. The current Finnish Hypertension Society guidelines and
the WHO-International Society of Hypertension guidelines define SBP < 120
mmHg and DBP < 80 to be optimal, SBP < 130 and DBP < 85 as normal, and SBP
> 140 and DBP > 90 as hypertension (Guidelines Subcommittee 1999; Suomen
Verenpaineyhdistys ry:n asettama työryhmä 2002).
The definition of hypertension in epidemiological studies usually relies on BP
measurements and information on current use of antihypertensive medication.
Casual BP measured with a classical mercury sphygmomanometer by the
auscultatory method is commonly used (WHO 1962; Aromaa 1981; Aromaa 1982).
Different BP limits have been used in epidemiological studies  (WHO 1962;
Aromaa 1981; Barker et al. 1998; Lloyd-Jones et al. 1999; Mosterd et al. 1999a;
Vasan et al. 2002). A single casual measurement overestimates the prevalence of
persistent high BP. However, suitably selected cut-off limits yield quite correct
prevalence estimates: a cut-off of SBP > 160 mmHg and DBP > 95 mmHg resulted
in an overestimate of only 2% (Aromaa 1982). The BP threshold levels for
defining hypertension have decreased over time. Thus, the proportion of persons
with hypertension who are receiving treatment and who have adequately controlled
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BP has risen (Kastarinen et al. 1998), while at the same time the proportion of
persons with elevated BP has decreased in the population (Laatikainen et al. 2003).
2.1.4.2 Occurrence and secular changes
The average level of BP in the Finnish population has decreased since the 1970s
(Vartiainen et al. 2000; Laatikainen et al. 2003; Vartiainen et al. 2003). BP levels
have decreased in all age groups, also among elderly (Aromaa et al. 2002). In an
international comparison, the BP levels in Finland were high both in men and
women in the 1980s (Wolf et al. 1997). The proportion of hypertensive persons
who were unaware of their condition fell from 1982 to 1997, and at the same time,
the proportion of hypertensive individuals with adequately controlled BP increased
(Kastarinen et al. 1998). The numbers of persons receiving drug treatment for
hypertension have steadily increased since the 1970s, mainly due to improved
coverage as well as changing indications of treatment (Aromaa et al. 1999; Data in
files of the Social Insurance Institution, Finland 2002). At the end of 2002, 8% of
working aged and 30% of persons aged 65 or more were entitled to drug
reimbursement for hypertension (Klaukka 2003).
2.2 Disability and burden imposed on society
2.2.1 Definition and measurement of disability in epidemiological
studies
The terms disability, impairment, functional limitation, activity limitation, dys-
function, disablement, and handicap have been used in a variety of ways in the
literature. The WHO International Classification of Functioning, Disability and
Health (ICF), published in 2001, provides a comprehensive description of human
functioning and its restrictions (World Health Organization 2001). The ICF
organizes information into two parts with two components: 1) functioning and
disability (the body functions and structures component and the activity and
participation component), and 2) contextual factors (environmental factors and
personal factors). Each component can be expressed in both positive and negative
terms. Impairment is the negative term for the body functions and structures
component, and activity limitations and participation restrictions for the activities
and participation component. The term disability serves as an umbrella term for
these three (impairment, activity limitation and participation restriction).
Impairments are problems in body function or structure. Activity limitations are
defined as difficulties an individual may have in executing activities, and
participation restrictions are problems experienced in involvement in life situations.
The former version of the WHO classification (World Health Organization 1980)
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used the terms impairment, disability and handicap. The new terms (body
functions and structures and activities and participation), which replace these
extend the scope of the classification to positive experiences.
Theoretical frameworks have been proposed to describe the pathway from disease
to disability (Nagi 1991). The conceptual framework of  Nagi’s model is organized
around distinctions among the concepts of pathology, impairment, functional
limitation, and disability (Nagi 1976; Nagi 1991). The conceptual scheme in the
former WHO classification (World Health Organization 1980) is organized around
four concepts: disease, impairment, disability, and handicap. ICF, the current WHO
classification, differs substantially from the 1980 version in the depiction of the
interrelations between functioning and disability. The new model is drawn to
illustrate multiple interactions between body functions and structures, activities,
participation, health condition, environmental factors, and personal factors. These
interactions work in two directions e.g. not only from a disease to disability, but
the presence of disability may modify the health condition.
In epidemiological studies, disability has been defined and measured in a variety of
ways (Branch et al. 1987; Jette et al. 1988; Bild et al. 1993; Guralnik et al. 1993;
Mäkelä et al. 1993). Disability is generally assessed through self-report or proxy
report of difficulty or need for help in different tasks. Additionally, physical
performance measures e.g. tests of standing balance, walking speed, or ability to
rise from a chair, have been used (Guralnik et al. 1994).
Functional status has commonly been defined in terms of ability to perform basic
activities of daily living (ADLs) and instrumental activities of daily living (IADLs).
Katz et al. introduced the original ADL scale that included six personal care
activities: eating, toileting, dressing, bathing, transferring from bed to chair, and
continence (Katz et al. 1963; Katz et al. 1970). These questions were originally
developed to assess the physical capabilities of older persons in long-term care or
rehabilitation, but are now widely utilized in population surveys. Continence is
typically not included in population estimates of ADL disability (Guralnik et al.
1993). These indicators identify the most severely disabled individuals. Walking a
short distance, such as across a room, has been incorporated by some as an ADL
measure (Branch et al. 1984). Different instruments have used a varying mix of these
activities. Minor variations in the wording of items may produce different estimates
of disability in similar populations (Wiener et al. 1990).
IADLs are tasks considered necessary for independent living in the community, but
are more difficult and complex than the self-care domain represented by ADLs.
Lawton and Brody  first introduced a scale with several of these activities,
including shopping, food preparation, housekeeping, doing laundry, using
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transportation, taking medications, handling finances, and using the telephone
(Lawton et al. 1969).
In addition to the ADLs and IADLs, a variety of other assessments of disability
have been utilized. Rosow and Breslau and Nagi developed the most widely cited
scales of more purely physical function (Rosow et al. 1966; Nagi 1976). Several
studies of disability use three items from the Rosow-Breslau scale: walking up and
down stairs to the second floor, walking a half-mile, and performing heavy house-
work. Items from the Organization for Economic Co-operation and Development
(OECD) disability questionnaire have also commonly used. In the 1970’s, the
OECD aimed to develop indicators of long-term disability for general population
surveys. The proposed items concentrate on physical functioning covering self-
care, mobility, and communication (McWhinnie 1981). However, no one set of
ADLs, IADLs, or higher order tasks most appropriate for defining disability exists
(Guralnik et al. 1993).  Prevalence estimates of disability vary according to the
items used to define disability.
In this thesis the term disability is used as a general term to mean activity limitations
indicating a need for help, and is measured by self-reports of difficulties in different
tasks. The tasks included mainly measure physical functioning.
2.2.2 Secular changes in disability
There are a number of cross-sectional surveys in Finland concerning the health and
functional capacity of elderly persons in one or two regions (Heikkinen et al. 1981;
Haavisto et al. 1984; Heikkinen et al. 1984; Heikkinen et al. 1990; Heikkinen et al.
1992; Valvanne et al. 1992; Sairanen et al. 1993; Lehtonen et al. 1994; Sakari-Rantala
et al. 1995; Niinistö et al. 1996; Winblad et al. 2001). Studies including information on
health and the need for care of elderly Finns, representative of the whole country, have
been interview or postal questionnaire surveys (Kalimo et al. 1982; Sauli et al. 1989;
Kalimo et al. 1992; Tyrkkö 1996; Lahelma et al. 1997; Arinen et al. 1998; Noro et al.
2000; Sulander et al. 2001), except for the Mini-Finland Survey in 1978–1980
(Aromaa et al. 1989b) and the Health 2000 Survey (Aromaa et al. 2002).
Findings from studies on secular trends in health and functional capacity of elderly
Finnish persons mainly suggest a slight decline in disability and the need for help
among the elderly (Ruikka et al. 1984; Jylhä et al. 1992; Pohjolainen et al. 1997;
Laukkanen et al. 1999; Pitkälä et al. 2001; Sulander et al. 2001; Aromaa et al.
2002; Malmberg et al. 2002; Martelin et al. 2002) although results vary between
age group, gender, and the measure of disability. Contradictory results have been
reported as well. In a study including a sample aged 60–89 years in Tampere in
1979 and 1989, there were only minor differences in functional ability between the
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cohorts. Only in the youngest age group (60–69 years) did difficulties with certain
ADL functions decline from 1979 to 1989 (Jylhä 1993). In two rural munici-
palities, Pyhäjärvi and Kärsämäki, in the district of Northern Ostrobotnia, no
change in the prevalence rates of disability among persons aged 75 or over was
observed from 1979 to 1989, nor to 1999 (Winblad 1993; Winblad et al. 2001). A
decline in the functional status of community-living persons aged 75 or over was
observed  from 1978 to 1988 in a rural community of Kuusamo in northern
Finland (Anttila 1991). The assessment of secular changes in functional capacity in
Finland, based on these studies, is difficult because the study populations have
usually been from one or two regions, and the methods and participation rates have
varied. In addition, institutionalized persons are not always included in the surveys.
Most studies on secular trends in functional capacity of the elderly in different
populations suggest that functional capacity has increased (Manton et al. 1997;
Ostir et al. 1999; Ahacic et al. 2000; Waidmann et al. 2000; Manton et al. 2001;
Freedman et al. 2002), but it has also been claimed that the observed secular
changes are fluctuations rather than consistent trends (Crimmins et al. 1997).
2.2.3 Chronic morbidity and disability
In many developed countries mortality is decreasing, and percentages and absolute
numbers of elderly individuals are increasing (World Population Ageing: 1950–2050
2001). The Finnish population in is also becoming older. The number of individuals
65 years of age or more will increase by over 70%, meaning an increase of 580 000
persons, by 2030. Within this age group, the most rapidly growing segment is
persons who are more than 80 years of age (Statistics Finland 2003b). The incidence
of many chronic diseases, including CHD, and the prevalence of disability increase
with increasing age (Guralnik et al. 1993; Andersen-Ranberg et al. 1999). The impact
of the aging population on the future disability burden depends on the developments
of chronic morbidity and functional ability of elderly individuals (Khaw 1999). The
burden of a chronic disease on society depends on its prevalence in each age group,
determined by its incidence and prognosis, the proportion and degree of disability
due to it, and the age structure and size of the population. In many societies, the
number of elderly is increasing at such a rate that despite a possible reduction of
incidence and prevalence of chronic disorders, the number of ill persons may
increase resulting in an increase in the need for care.
Health problems are the main cause of disability (Guralnik et al. 1996; Fried et al.
1997). Activity limitations are important determinants of quality of life and need
for help. Disability is also a major risk factor for dependency and institu-
tionalization (Fried et al. 1994). As the number of chronic conditions increases,
disability rises rapidly (Verbrugge et al. 1989). The type of disease is also important
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in determining disability. The impact of disease on disability is, however, modified
by the individual’s age, gender, social support, and other factors in the environment
(Fried et al. 1997). Disability prevalence is higher in women than in men, especially
at advanced age (Guralnik et al. 1993; Fried et al. 1997; Andersen-Ranberg et al.
1999), possibly arising from the greater longevity of females at any given level of
functional impairment (Manton 1988; Strawbridge et al. 1992).
A number of chronic conditions associated with aging are consistently found to be
strongly related to disability (Stewart et al. 1989; Verbrugge et al. 1989; Guralnik
et al. 1996; Stuck et al. 1999). Different chronic conditions are likely to have a
different impact on functional ability. There are only a few studies examining the
degree to which particular chronic conditions contribute to disability and
dependency (Stewart et al. 1989) and the proportion of disability in the population
attributable to specific medical conditions (Mäkelä et al. 1993; Guccione et al.
1994). Both prevalence and disability impact of a condition are important
determinants of the disability burden caused by it (Verbrugge et al. 1989).
2.2.3.1 Cardiovascular diseases and disability
In cross-sectional studies an association has been found between disability and
CVDs (Lammi et al. 1989a), particularly CHD (Verbrugge et al. 1989; Pinsky et al.
1990; Ettinger et al. 1994; Guccione et al. 1994; Fried et al. 1999) and stroke (Jette
et al. 1988; Verbrugge et al. 1989; Ettinger et al. 1994; Guccione et al. 1994; Fried
et al. 1999). CVDs have also predicted future disability in longitudinal studies
(Konu 1977; Harris et al. 1989; Keil et al. 1989; Lammi et al. 1989b; Lammi et al.
1990; Nickel et al. 1990; Boult et al. 1994). A recent prospective study showed that
acute MI and congestive heart failure decrease physical functioning, and these
negative consequences are not temporary (van Jaarsveld et al. 2001). Of stroke
survivors, one third remained disabled (Hankey et al. 2002). It has been suggested
that women with CVD are at higher risk for subsequent decrease in function, than
are men (Chirikos et al. 1984; Nickel et al. 1990; van Jaarsveld et al. 2002).
Very few studies have examined the functional capacity of persons suffering from
CVDs in a non-selected population (Pinsky et al. 1990; Ahto et al. 1998). Usually,
the studies concern individuals selected by the severity of the disease (Nickel et al.
1990; van Jaarsveld et al. 2001). Research on the importance of specific CVDs in
comparison with each other, and on CVDs as determinants of disability compared
to other chronic conditions, has been scarce (Stewart et al. 1989; Guccione et al.
1994).
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2.2.4 Coronary heart disease and disability burden
It is estimated that the burden caused by CVDs will increase during the coming
decades (Sans et al. 1997; Beller 2001). Also in Finland, aging of the population may
lead to a substantial increase in the number of patients with CHD, and the average
age of the patients will markedly increase (Aromaa et al. 1999; Statistics Finland
2003b). The burden of CHD on society depends on the need for care and
consequences of the disease, determined by incidence, prevalence, and severity.
Mortality and incidence have recently changed due to changes in life style and
treatment (Vartiainen et al. 1994b; Salomaa et al. 1996a; Salomaa et al. 2003).
To understand the current and future burden imposed by CHD, it is important to be
aware of secular trends. Changes in both the prevalence of CHD and in the functional
capacity of persons suffering from these diseases are important determinants of the
disability burden. There are no population-based studies in Finland on secular trends
in functional capacity among persons suffering from chronic CHD. It is not known
how the functional ability of CHD patients has changed when CHD mortality has
decreased, CHD morbidity has been postponed to older ages, and due to better
treatment more CHD patients have survived (Abrahamsson et al. 1998; Rosamond et
al. 1998; Salomaa et al. 1999; Tunstall-Pedoe et al. 2000).
2.2.5 Disability as a predictor of mortality
It is well known that disability is associated with increased risk of death. Several
studies have found disability to be a strong predictor of mortality, both in the
community-dwelling elderly and in those who have been institutionalized (Koyano
et al. 1986; Reuben et al. 1992; Brock et al. 1994; Corti et al. 1994; Guralnik et al.
1994; Corti et al. 1996; Guralnik et al. 1996; Scott et al. 1997; Fried et al. 1998;
Inouye et al. 1998; Ostbye et al. 1999; Ostir et al. 1999; Hirvensalo et al. 2000;
Ramos et al. 2001). Physical disability was an independent predictor of CHD
mortality in both older men and women, and for CHD incidence only in women
(Corti et al. 1996). Functional restrictions of ADL prior to MI are important
predictors of clinical severity and mortality in elderly MI patients in acute clinical
settings (Brezinski et al. 1991; Vaccarino et al. 1997). However, knowledge on the
impact of disability as a predictor of mortality and other complications in persons
with CHD is based almost exclusively on study populations drawn from clinical
settings or otherwise not representing general populations (Spertus et al. 2002).
Cardiac rehabilitation improves physical functioning among CHD patients, also
among the elderly (Ades 1999; Ades et al. 1999; Pasquali et al. 2001). In ran-
domized trials, intervention programmes reducing disabilities have been shown to
improve the prognosis of patients with acute MI (Kallio et al. 1979). It can also be
assumed that similar interventions would improve the prognosis of people with
CHD in the general population.
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3 AIMS OF THE STUDY
The general aim of the study was to examine the impact of CVDs as determinants
of disability in elderly Finns. The specific aims of the study were to:
1. examine secular changes in the prevalence of CVDs in Finland over the past
20 years (I)
2. describe the functional capacity of persons suffering from specific CVDs,
and to estimate the importance of these diseases as determinants of activity
limitations and need for help in elderly Finns (II)
3. examine changes over time in the prevalence of disability and need for help
in persons with and without CHD, and to analyze secular changes in the
disability burden at population level due to changes in the prevalence of
CHD and in the CHD-related disability (III)
4. assess the impact of disability on mortality in persons with and without
CHD (IV)
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4 MATERIALS AND METHODS
4.1 Health examination surveys
The studies in this thesis used data from three population-based cross-sectional
health examination surveys (Table 1) undertaken in Finland from 1978 to 1980
(Mini-Finland Health Survey) (Lehtonen et al. 1986; Aromaa et al. 1989a; Aromaa
et al. 1989b), in 1997 (FINRISK-97 Senior Survey)(Martelin et al. 1998), and from
2000 to 2001 (Health 2000 Survey) (Aromaa et al. 2002). Largely similar methods
were used in these three surveys. One study (IV) was based on the Mini-Finland
Health Survey (from 1978 to 1980), with mortality follow-up until the end of 1994.
4.1.1 The Mini-Finland Health Survey
The Mini-Finland Health Survey comprised several phases. In the first phase
nurses interviewed study subjects in their homes or the institutions in which they
were living. The subjects were then invited to attend the second phase, a health
examination. In the first part of the health examination (screening examination),
self-administered health questionnaires were reviewed, interviews of symptoms
performed, height, weight, and BP measured, ECG registered, and blood samples
taken. Subjects with chronic disease histories, symptoms, or findings suggestive of
cardiovascular, respiratory, or musculoskeletal diseases were asked to participate in
the second part of the health examination, a clinical phase involving a standardized
physical examination.
The screening procedure was effective: in a validation sample (N = 1 321) invited
to participate in the second phase regardless of screening status, the sensitivity of
Name of  
survey
Survey
period
Representativeness Samples Age range
(years)
Sampling 
method
Mini-Finland 
Health Survey
1978–1980 Representative of the whole 
Finnish population of 30 years 
of age or more
8 000
(3 637 men and 
4 363 women)
30–99 Two-stage 
sampling 
design
FINRISK-97 
Senior Survey
1997 Two areas: North Karelia and 
the capital city region (Helsinki 
and Vantaa)
1 500 
(500 men and 250 
women in both 
areas)
65–74  Random 
population 
sample 
Health 2000 
Survey
2000–2001 Representative of the whole 
Finnish population of 30 years 
of age or more
8 028 
(3 637 men and 
4 391 women)
30–99  Two stage 
sampling 
design
Table 1. Characteristics of the population-based cross-sectional health
examination surveys.
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screening was 100% for AP, 100% for MI, 100% for heart failure, and 97% for any
CVD.
4.1.2 The FINRISK-97 Senior Survey
The FINRISK-97 Senior Survey belongs to a series of cross-sectional population
surveys conducted every fifth year in Finland since 1972 (Vartiainen et al. 1995;
Vartiainen et al. 1998). Earlier surveys covered only middle-aged individuals. In
1997, Finns 65–74 years of age were included in two areas of the FINRISK
Survey. The FINRISK Senior Survey was carried out in North Karelia, an area in
which cardiovascular morbidity has been high, and in Helsinki and Vantaa, the
capital and a neighbouring city, in which morbidity has been intermediate i.e. at
the national level (Joensuu 1989). The purpose of the FINRISK Senior Survey was
to determine changes since the late 1970s by comparing findings with those from
the Mini-Finland Survey.
The FINRISK-97 Senior Survey protocol was implemented via a one-phase field
examination complemented by home visits to non-participants. A self-administered
questionnaire was included in each letter of invitation. Completed questionnaires
were reviewed at field examination sites. Trained nurses conducted interviews
about health, previous diseases, functional ability and the need for help, following
detailed written instructions and using a structured interview form. BP, height and
weight were measured. Cognitive function was measured by a shortened form of
the Mini Mental State Examination (MMSE) (Magaziner et al. 1987). In Helsinki
and Vantaa resting ECG were recorded. Field examinations ended with standard-
ized physical examinations by physicians. Nurses visited the homes of individuals
who did not attend field examinations.
4.1.3 The Health 2000 Survey
The Health 2000 Survey was a health interview and examination survey carried out
in Finland from fall 2000 to spring 2001 (Aromaa et al. 2002). One of its aims was
to determine changes in health, functional ability and the need for help from 1978–
80. A two stage sampling design was used, and for the population aged 80 years
and over the sampling probability was twice as high as among those aged under
80. First, a home interview was conducted. After one to six weeks the examinees
received an invitation to attend a comprehensive health examination including
questionnaires, measurements (e.g. BP and resting ECG) and a doctor’s physical
examination. Nurses visited the homes of individuals who did not attend field
examinations.
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4.2 Study populations
Different sample constructions were used according to the purpose of each original
study. The participation rates of the surveys were high – 90% of men and 87% of
women participated in the health examination of the Mini-Finland Health Survey
in 1978–1980. In the FINRISK-97 Senior survey, 86% of men and women
participated in the field or home health examinations. In the Health 2000 Survey,
80% of men and 77% of women participated in the field health examination.
However, the participation rates were lower in the oldest age group; 65% of men and
54% of women aged 75 years or more participated in the field health examination of
the Health 2000 Survey. A substantial proportion of elderly non-participants were
examined at home by nurses. The extent of the home examination was, however,
more limited than the health examination proper (Table 2).
Study populations of original articles are shown in Table 3. Studies I and III were
based on two cross-sectional national population surveys carried out 20 years
Men Women
Sa
m
pl
e
Inter-
viewed 
at home
Health 
examined
Health 
examined 
at home
Sa
m
pl
e
Inter-
viewed
at home
Health 
examined
Health 
examined 
at home
N % N % N % N % N % N %
Mini-Finland 
Survey
45–64 1 499 1 448 96.6 1 384 92.3 - - 1 704 1 640 96.2 1 573 92.3 - -
65–74 490 470 95.9 436 89.0 - - 760 719 94.6 642 84.5 - -
75–99 201 193 96.0 159 79.1 - - 447 424 94.9 307 68.7 - -
45–99 2 190 2 111 96.4 1 979 90.4 - - 2 911 2 783 95.6 2 522 86.6 - -
FINRISK-97 
Senior Survey
65–74 1 000 - - 739 73.9 119 11.9 500 - - 374 74.8 56 11.2
Health 2000 
Survey
45–64 1 575 1 374 87.2 1 301 82.6 37 2.3 1 627 1 485 91.3 1 430 87.9 32 2.0
65–74 422 378 89.6 345 81.8 22 5.2 571 497 87.0 461 80.7 25 4.4
75–99 324 279 86.1 212 65.4 45 13.9 840 680 81.0 450 53.6 188 22.4
45–99 2 321 2 031 87.5 1 858 80.1 104 4.5 3 038 2 662 87.6 2 341 77.1 245 8.1
Table 2. Participation rates in the health surveys.
.
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apart, study II was an association study in a cross-sectional cohort, and study IV
was a prospective cohort study.
4.3 Study variables and definitions
4.3.1 Coronary heart disease
Definition of CHD was based on different sources according to the purposes of
each original study. Answers to similarly worded standard questions relating to
known diseases were available from the largest numbers of participants in all three
surveys. For studies I, II and III, answers to the question “Has a doctor ever
diagnosed that you suffer from one of the following diseases 1) angina pectoris, 2)
myocardial infarction?” were used. CHD was defined as AP or history of MI.
In studies I, II and IV, clinical diagnoses of AP and MI were used. Trained
physicians followed detailed written instructions, and applied uniform diagnostic
criteria in accordance with good clinical practice in standardized physical
examinations. The diagnostic criteria used in the surveys were similar. The
examining physician critically assessed the disease and symptom history, and
available documents and performed a structured physical examination. Diagnostic
assessments were recorded on structured forms. AP was defined as typical chest
pain brought on by exertion and relieved by nitroglycerine or by rest. MI was
defined as a positive history in the medical records, old MI on ECG, or typical
self-reported history of MI treated in hospital. Any CHD was defined as AP, MI,
history of coronary by-pass surgery, or angioplasty.
Table 3. Study populations of original publications.
Study Surveys Age 
range 
(years)
Participants
I Mini-Finland Health Survey 
1978–1980 and FINRISK-97 
Senior Survey 1997
65–74 436 men and 642 women (Mini-Finland)
858 men and 430 women (FINRISK-97 Senior Survey)
II FINRISK-97 Senior Survey 
1997
65–74 858 men and 430 women
III Mini-Finland Health Survey 
1978–1980 and Health 2000 
Survey 2000–2001
45–99 1  975 men and 2 521 women (Mini-Finland)
1 850 men and 2 334 women (Health 2000)
IV Mini-Finland Health Survey 
1978–1980 with mortality 
follow-up until the end of 1994
45–99 1 979 men and 2 522 women were followed-up; 
897 men and 846 women died during follow-up
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4.3.1.1 Mortality from coronary heart disease
Data on causes of death obtained from Statistics Finland were linked to the study
data by personal identification numbers. Coverage of the mortality register based
on death certificates was almost complete, including emigrants who died abroad.
The codes 4100A–4149X of ICD-9 (International Classification of Diseases, ninth
revision) were used for CHD as the cause of death (study IV).
4.3.2 Other cardiovascular diseases
In studies I and II other CVDs were also considered. Both self-reported and
clinical diagnoses were used.
4.3.2.1 Self-reported other cardiovascular conditions
Chronic morbidity was assessed by the question: “Has a doctor ever diagnosed that
you suffer from the following diseases: 1) hypertension or high blood pressure, 2)
heart failure, 3) stroke or 4) intermittent claudication?”
4.3.2.2 Clinical diagnoses of other cardiovascular conditions
Hypertension was diagnosed if an individual took blood-pressure medication or
had SBP of 160 mmHg or above and DBP of 95 mmHg or above. This
classification of hypertension, which is not exactly the same as the WHO
recommendation, was used in order to avoid overestimation of the prevalence of
persistent high BP, and to be comparable with the definition used in the Mini-
Finland Health Survey. In study IV, a four-category classification was used (see
later). Heart failure was defined as congestive heart failure according to medical
records or definite self-reported history of diagnosed congestive heart failure.
Cerebrovascular disease was defined as positive history of cerebrovascular attack
in the medical records or definite self-reported history of an attack diagnosed by a
doctor. Intermittent claudication was defined as positive history of intermittent
claudication in the medical records, previous bypass surgery, angioplasty or other
operation for peripheral vascular disease, or definite self-reported history of
intermittent claudication.
4.3.2.3 Any cardiovascular disease, any cardiovascular disease except
hypertension and any heart disease
In analyses concerning self-reported history of diseases and clinical diagnoses, any
CVD means MI, AP, hypertension, heart failure, cerebrovascular disease, or
intermittent claudication. Any CVD except hypertension means any of these
diagnoses except hypertension alone. Heart disease means MI, AP, or heart failure.
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4.3.3 ECG findings
ECG data was used in study I. ECG findings were coded using the Minnesota
code. Probable old MI included Minnesota codes 1.1 or 1.2 together with 5.1–2.
Other ischaemic ECG changes indicating possible CHD included Minnesota codes
1.2 without 5.1–2, 1.3, 4.1–3, 5.1–2, 6.1–2, 7.1–2, 7.4, or 8.3 (I) (Reunanen et al.
1983).
4.3.4 Other chronic diseases
The health interview also elicited information on other chronic diseases. In the
analysis, these were combined into five larger groups: diabetes, respiratory
diseases, musculoskeletal disorders, other somatic diseases, and mental disorders.
In the analysis restricted to those subjects who attended the clinical examination,
the diagnoses of other chronic diseases were based on clinical diagnoses made by
physicians (II).
4.3.5 Disability
The health interviews and health questionnaires elicited information on whether
the person could perform certain activities without difficulty, with some
difficulties, with marked difficulty, or not at all: 1) moving about in the house, 2)
getting in and out of bed, 3) dressing and undressing, 4) carrying a shopping bag of
5 kg, 5) walking 400 m (500 m without rest in study III), 6) climbing a flight of
stairs (without rest in study III), 7) managing grocery shopping, 8) clipping one’s
toenails, 9) reading a newspaper, 10) performing heavy housework such as
cleaning, and 11) travelling on public transport. This series of questions was
modified from the classification of functional capacity initially introduced by Katz
et al. and Lawton et al. (Katz et al. 1963; Lawton et al. 1969; Katz et al. 1970) by
also including the OECD disability questionnaire (McWhinnie 1981), and it has
been used in a national survey to estimate the occurrence of disability (Aromaa et
al. 1989b; Mäkelä et al. 1993).
For the purposes of each original report, definitions of disability based on the
above mentioned questions were used. For study II, disability was defined as being
unable to perform without help at least one of tasks 1–11. In study IV, disability
was defined as either being unable to perform without help or having marked
difficulty in performing at least one of tasks 1–11. This broader definition was
used in order to obtain enough observations in every category at baseline and
during mortality follow-up. For study III, disability was defined as either being
unable to perform without help or having marked difficulty in performing at least
34
one of tasks 1–7. The availability of comparable information limited the use of
tasks 8–11 in this substudy. Persons who were almost or totally blind were also
considered to be disabled.(Aromaa et al. 1989b; Mäkelä et al. 1993)
4.3.6 Cognitive impairment
Cognitive impairment was included in the analyses of study II. The shortened form
of the MMSE (Folstein et al. 1975; Magaziner et al. 1987) included 9 of the 19
original MMSE questions. A score of less than 14 (maximum 19) on the shortened
MMSE, corresponding approximately to the lowest quintile in the age group under
consideration (65–74 years), was taken to indicate cognitive impairment.
4.3.7 Obesity
Height and weight were measured and body mass index (BMI) weight/height2, kg/m2
calculated. A body mass index (BMI) of 30 or more was defined as obesity (study
II). A four-category classification was used in study IV.
4.3.8 Blood pressure
Casual BP was registered in the sitting position after a 5-min rest by the
auscultatory method. The subjects were classified into four hypertension classes
based on the levels of SBP and DBP and the possible use of antihypertensive
medication (Aromaa 1981). Persons with SBP > 170 mmHg and DPB > 100
mmHg and those using antihypertensive drugs were considered to be definitely
hypertensive. Of the remaining study population, those with SBP > 160 mmHg and
DBP > 95 mmHg were considered to have mild hypertension, and those with SBP
< 140 mmHg and DBP < 90 mmHg were considered to be normotensive. All other
persons were considered to have borderline hypertension (study IV).
4.3.9 Other variables
Serum samples were taken and cholesterol concentration determined by an auto-
analyzer modification of the Liebermann-Burchard reaction (in the Mini-Finland
Health Survey) (Carr et al. 1956). Quintiles of total cholesterol were used in the
analyses. The health interview provided information on smoking habits. The
subjects were classified according to smoking 1) as those who had never smoked,
2) former smokers, 3) current smokers of cigars or pipes only or < 20 cigarettes per
day, and 4) current smokers of > 20 cigarettes per day (study IV).
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4.4 Statistical methods
4.4.1 Means and prevalences
Age-adjusted means of baseline risk factors were calculated using a linear model
(Lee 1981). Prevalences adjusted for age were estimated using a logistic model (I
and III) (Breslow et al. 1987). Statistical significance of differences between
prevalences was tested using the likelihood ratio test based on the model.
Estimation of age-adjusted prevalences of disability in persons with and without
CHD in the 1978–1980 and the 2000–2001 surveys was performed by including
age (years), CHD, survey and an interaction term between CHD-status and survey
in the model (III).
4.4.2 Mortality
The Cox proportional hazards model was used to estimate age-adjusted and
multivariate adjusted relative risks (RR) for all-cause and CHD mortality among
disabled and non-disabled persons with and without CHD (Cox 1972). Follow-up
time was considered as the time from the Mini-Finland baseline examination date
(1978–1980) to death, date of withdrawal, or the end of 1994, whichever came
first. In order to obtain age-adjusted RRs for persons in various subgroups at
baseline age, CHD, disability, and an interaction term between baseline CHD-
status and disability were included in the model.
4.4.3 Impact of cardiovascular diseases and other chronic
diseases on disability
The relationship between disability and its determinants was assessed using the
logistic model. Odds ratios (OR) with 95% confidence interval (95% CI) obtained
with the model were calculated to assess the association between disability and
various CVDs and other specific chronic diseases (II, III). In study III, an
interaction term between CHD-status and survey was included in the model in
order to assess the importance of CHD as a determinant of disability in the 1978–
1980 and 2000–2001 surveys.
To understand the impact of each chronic condition in terms of its prevalence as
well as its odds of disability, the proportion of disability attributable to each
condition was computed as an adjusted attributable fraction (Greenland 1984)
(study II).
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4.4.4 Assessment of the impact of the changes in coronary heart
disease on disability
In study III, attributable fractions were estimated by the method of Greenland and
Drescher (Greenland et al. 1993) on cohort studies, and a Stata macro called aflogit
by Tony Brady (PHLS Statistics Unit, London).
In order to assess the proportion of change in the prevalence of disability explained
by changes in the prevalence of CHD and in CHD-related disability, we used the
following formula:
(PDCHD2000 – PDCHD1980) / (PD2000 – PD1980) x 100
where
PDCHD1980 = AF1980 x PD1980  is the prevalence of disability due to CHD in the
population in 1978–1980,
PDCHD2000 = AF2000 x PD2000 is the prevalence of disability due to CHD in the
population in 2000–2001,
AF1980 is the attributable fraction for CHD in 1978–1980,
AF2000 is the attributable fraction for CHD in 2000–2001,
PD1980 is the age-adjusted prevalence of disability in the population in 1978–1980,
and
PD2000 is the age-adjusted prevalence of disability in the population in 2000–2001.
4.4.5 Statistical software
Statistical analyses were carried out with SAS, Release 6.12 (SAS Institute Inc.,
Cary, NC, USA). STATA, Release 7.0 (StataCorp., College Station, TX, USA) and
the aflogit Stata macro (by Tony Brady, PHLS Statistics Unit, London) were used
to calculate attributable fractions (in study III).
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5 RESULTS
5.1 Secular changes in the prevalence of cardiovascular
diseases
The prevalence of CHD based on health interview was lower in men and women
aged 45 to 64 years in the 2000–2001 survey than in the 1978–1980 survey, but in
the age group 65–74 no significant difference was observed. In those aged 75 years
or more the prevalence of CHD was higher in the 2000–2001 survey than in the
1978–1980 survey (Figure 1; study III, Table 1). Results of study I, concerning
prevalence of CHD among persons aged 65–74 years based on answers to
structured disease questions, are in line with the results of study III. (Figure 2;
Study I, Table 3).
Results based on clinical diagnoses suggest that the prevalence of clinically
diagnosed AP and of any manifestation of CHD were significantly lower in the
1997 survey than in the 1978–1980 survey in men and women aged 65–74 years.
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Figure 1. Age-adjusted prevalence of CHD in Finland in 1978–1980 and 2000–
2001.
*  p < 0.05, **  p < 0.01, ***  p < 0.001
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No significant difference was observed in relation to previous MI. In resting ECGs
the prevalence of large Q-waves, indicating previous MI, was significantly lower
in men in the 1997 survey than in the 1978–1980 survey, whereas no correspon-
ding decline was observed in women. The prevalence of any ischaemic ECG
change, indicating possible CHD, was significantly lower in the 1997 survey than
in the 1978–1980 survey in both genders (study I, Table 2).
The proportion of persons using antihypertensive drugs or having SBP of 160
mmHg or above and a DBP of 95 mmHg or above was markedly higher in men
and lower in women in the 1997 survey than in the 1978–1980 survey (Figure 3;
study I, Table 2). The increase in men was probably due to the increased use of
antihypertensive medications. In the late 1970s, 17% of men and 33% of women
used antihypertensives, whereas in the 1997 survey the corresponding proportion
was 29% in men and 27% in women. In both genders the prevalence of clinically
diagnosed heart failure had declined substantially. No significant change was
observed in the prevalence of cerebrovascular disease (Figure 3; study I, Table 2).
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CD = clinical diagnoses
IW = interview (answers to structured disease questions)
* p < 0.05, ** p < 0.01, ***  p < 0.001
Figure 2. Age-adjusted prevalence of CHD among persons aged 65–74 years
according to clinical diagnoses by field physicians and answers to structured
disease questions.
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The prevalence of any CVD was significantly lower in women aged 65-74 years in
the 1997 survey than in the 1978–1980 survey. The corresponding reduction in
men was not statistically significant. The prevalence of any CVD except
hypertension and of heart diseases were significantly lower in 1997 than in 1978–
1980 in both genders (Figure 3; study I, Tables 2 and 3).
5.2 Cardiovascular diseases as determinants of disability
In 1997, 10% of men aged 65–74 years and 16% of women in this age group were
disabled according to the definition used (study II, Table 1). Disability was over
four times as common in the population examined at home than examined in the
field. The prevalence of disability was particularly high among men and women
suffering from cerebrovascular disorders (disability prevalence in men 31%, in
women 44%) and mental disorders (men 40%, women 42%). Disability was
common also among women with previous MI (46%) or suffering from heart
failure (37%) (study II, Table 2).
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Figure 3. Age-adjusted prevalence of different CVDs in men and women aged
65–74 years according to clinical diagnoses by field physicians.
HT = Hypertension, HF = Heart failure, CD = Cerebrovascular disease, AHD =
Any heart disease, ACVD = Any cardiovascular disease
* p < 0.05, ** p < 0.01, *** p < 0.001
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Each CVD, except hypertension, was significantly associated with disability in
men after adjustment for age. In age-adjusted analyses on women, MI, heart
failure, hypertension, and cerebrovascular diseases were associated with disability.
After adjustment for comorbidity, only cerebrovascular diseases (OR = 4.1, 95%
CI = 1.9–8.5) were significantly associated with disability in men, while in women
MI (OR = 4.9, 95% CI = 1.8–13.4), heart failure (OR = 2.5, 95% CI = 1.04–5.8),
and cerebrovascular disease (OR = 3.3, 95% CI = 1.2–9.3) remained significant
determinants of disability (Figure 4; study II, Table 4). In the analyses based on the
clinical diagnoses obtained in the field examination, intermittent claudication also
was a significant determinant of disability in men. The ORs obtained from these
analyses were somewhat higher but essentially similar to those obtained from the
analyses based on health interview data.
Of other chronic conditions, mental disorders were the most strongly associated
with disability in both genders (OR = 7.1, 95% CI = 3.6–14.0 for men and OR =
4.7, 95% CI = 2.2–9.7 for women). Other determinants of disability, after
adjustment for comorbidity, included diabetes, impaired cognition, and obesity in
men, whereas only mental disorders were a significant determinant of disability in
women (study II, Table 3).
0
2
4
6
8
10
12
14
MI AP HF HT IC CD MI AP HF HT IC CD
Odds
ratio
WomenMen
Figure 4. Cardiovascular diseases as determinants of disability among Finns
aged 65–74 years (multivariate adjusted odds ratios).
MI = Myocardial infarction, AP = Angina pectoris, HF = Heart failure, HT =
Hypertension, IC = Intermittent claudication, CD = Cerebrovascular disease
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To identify the public health impact of each determinant of disability in the age
group covered by study II (65–74 years), the proportion of disability attributable to
each condition was estimated. After adjustment for comorbidity, the population
attributable fraction for any CVD, excluding hypertension alone, was 24% in
women and 33% in men. Mental disorders, cognitive impairment, and obesity were
the other important contributors to disability, with attributable fractions of around
20%. Of the CVDs, cerebrovascular disease (16%), MI (14%), and AP (13%) in
men, and MI (20%), heart failure (18%), and cerebrovascular disease (11%) in
women, had the highest attributable fractions (study II, Table 5).
5.3 Secular changes in CHD-related disability burden in
Finland from 1978–1980 to 2000–2001
5.3.1 Prevalence of disability
In both genders the prevalence of disability had significantly declined from the
1978–1980 survey to the 2000–2001 survey until the age of 75 years. The decrease
was not statistically significant in the oldest age group (study III, Table 1).
In the 65–74 years age group, 37% of men and 44% of women with CHD were
disabled in 1978–1980, whereas 20% of men and 39% of women were disabled in
2000–2001, according to the definition of disability used. In men, regardless of
CHD status, the prevalence of disability had decreased significantly in the 45–64
and 65–74 age groups. The decrease was smaller and not statistically significant in
the 75 or over age group. The decreases in the prevalence of disability were not
statistically significant in women with CHD. Prevalence of disability was
significantly lower in the 2000–2001 survey than in the 1978–1980 survey in the
45–64 and 65–74 age groups in women without CHD (Figure 5; Study III, Table 4).
5.3.2 Contribution of coronary heart disease to disability
In men aged 45–64 and 65–74 years, 19–20% of disability was attributable to
CHD in the 1978–1980 survey, and 16% in the 2000–2001 survey. In women the
corresponding numbers were 10% in the 45–64 age group and 12% in the 65–74
age group in the 1978–1980 survey and 6% and 18% in the 2000–2001 survey. In
the oldest age group of 75 years or over, 5% of disability in 1978–1980 and 6% in
2000–2001 was attributable to CHD in men. In women, the corresponding
numbers were 8% and 10%. (Figure 6; study III, Table 3)
42
0
10
20
30
40
50
60
70
80
90
CHD
no
CHD
45–64 65–74 75 +
%
1978–1980 2000–2001
Men Women
CHD status
Age group
(years)
CHD
no
CHD CHD
no
CHD CHD
no
CHD CHD
no
CHD CHD
no
CHD
45–64 65–74 75 +
0
5
10
15
20
25
45–64 65–74 75 + 45–64 65–74 75 + Age group
(years)
%
1978–1980 2000–2001
Men Women
Figure 5. Prevalence of disability in men and women with and without CHD in
1978–1980 and 2000–2001.
Figure 6. Percentage of disability attributable to CHD.
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5.3.3 Contribution of coronary heart disease to the decline in
disability from 1978–1980 to 2000–2001
The decrease in the prevalence of CHD together with the decrease in disability due
to CHD explained a fifth of the whole decrease in disability in Finnish men aged
45–64 years during the past 20 years. In men aged 65–74 years, these two factors
explained a fourth of the decrease in the disability. Among women aged 45–64
years, the contribution of CHD was estimated to be 17%. Among older men and
women, CHD did not contribute to the functional ability changes at the population
level (study III, Figure 1).
5.4 Disability as a predictor of mortality in persons with and
without coronary heart disease
Disability in men increased the risk of death from CHD and all-causes regardless
of CHD status at baseline, even after adjustment for potential cardiovascular risk
factors (Study IV, Table 2). In women free of CHD at baseline, disability was
related to increased total and CHD mortality, but no significant association was
observed in women with baseline CHD (Figure 7; study IV, Table 2).
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Figure 7. Relative risk of death (with 95% confidence intervals) associated with
disability in men and women according to CHD status at baseline.
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In comparison to persons with neither CHD nor disability, the multivariate adjusted
RR of CHD mortality was 4.4 (95% CI = 3.3–5.9) in disabled men with CHD at
baseline and 2.5 (95% CI = 1.8–3.6) in the corresponding group of women. CHD
at baseline increased CHD mortality about 3-fold both in men with and without
disability. In women the corresponding RR associated with CHD at baseline was
about 2 regardless of disability status (Table 4).
The impact of disability on mortality was examined in different age groups.
Disability was independently related to increased CHD and total mortality in men
with baseline CHD after adjustment for potential cardiovascular risk factors,
except in the oldest age group (75 years or over). In women with CHD at baseline,
disability was not significantly associated with mortality from CHD or all-causes.
In men free of baseline CHD, disability was a statistically significant predictor of
mortality from all-causes in the 45–64 and 65–74 age groups, and from CHD in
the 65–74 age group. In women free of baseline CHD, disability predicted excess
all-cause mortality in all age groups and CHD mortality among those aged 45–64
years (study IV, Table 3).
Table 4. Relative risks (RR) of death with 95% confidence intervals (CI) from
coronary heart disease (CHD) and all-causes according to disability and CHD at
baseline.
Subjects without CHD Subjects with CHD
No disability Disability No disability Disability
RR RR CI RR CI RR CI
Men
CHD mortality 1.0 (Referent) 1.3 1.0, 1.8 3.0 2.2, 4.1 4.4 3.3, 5.9
All-cause mortality 1.0 (Referent) 1.5 1.2, 1.8 1.7 1.4, 2.1 2.9 2.4, 3.5
Women 
CHD mortality 1.0 (Referent) 1.4 1.0, 2.0 2.2 1.4, 3.7 2.5 1.8, 3.6
All-cause mortality 1.0 (Referent) 1.5 1.3, 1.7 1.3 1.0, 1.7 1.4 1.2, 1.8
Cox proportional hazards model included age (years), CHD-status, disability, and the interaction term between CHD-status 
and disability, body mass index (< 20, 20–24.99, 25–29.99, 30–34.99, ≥ 35), hypertension (4 classes), total cholesterol 
(quintiles), smoking status (never, past, and current smoking of 1 to 19, and ≥ 20 cigarettes per day), and diabetes.
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6 DISCUSSION
6.1 Population
The validity of our results on secular trends depends first on the representativeness
and comparability of the study samples, and second, on the comparability of the
information on chronic morbidity and disability. In the 1978–1980 and the 2000–
2001 surveys the samples were representative of the entire adult population of
Finland. In the 1997 survey the sample was from two regions, in which morbidity
from CVD has been high and moderate (Joensuu 1989; Aromaa et al. 1999). Our
results in study I relate to all subjects aged 65–74 years in the 1978–1980 and 1997
surveys. Separate analyses were undertaken in which the 1997 survey results were
compared with those in the corresponding geographical regions in the 1978–1980
survey. Results of these subsample comparisons and the consequent conclusions
were no different from those of the larger-scale comparisons (data not shown).
Participation rates in all surveys were high. Still, participation rates were higher in
the 1978–1980 survey than in later surveys, reflecting a general trend of decreasing
participation in many countries. Since non-participation is selective with regard to
disability, resulting in underestimation of the most severe disability, the decline in
participation may have led to an underestimation of the prevalence of both
disability and severe CVD in the later surveys. The overall decline in the
prevalence of disability from 1978–1980 to 2000–2001 was, however, equally
pronounced when we analyzed data based on home health interviews, for which
information was available for 90% of the sample in 2000–2001 (Aromaa et al.
2002). Comparisons were also made with the Mini-Finland Health Survey (1978–
1980) health examination data and the Health 2000 Survey (2000–2001) field and
home health examination data (data not shown). These comparisons did not alter
the basic conclusions drawn from the results concerning field health examinations
of the two surveys. These analyses confirm the results suggesting that functional
capacity of persons aged 75 years or more has not increased over the past 20 years.
Depending on the purposes of each substudy, different groups of participants were
chosen for the analyses. Careful attention was paid to the comparability of the
results because the subpopulations included in the analyses influence on the
results.
High participation rates, inclusion of institutionalized persons, and home
examinations conducted for persons who could not attend the field examination
were particular strengths of study II. In many previous studies subjects have been
lost if they were unable to attend the examination due to medical conditions
causing functional limitations (Jette et al. 1988; Verbrugge et al. 1989; Guccione et
al. 1994). Such functional ability and health-related selection obviously tends to
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bias the observed association between disease and disability (Hoeymans et al.
1998). Selection bias of CHD patients according to the severity of the disease,
which may occur in studies based on a clinical series (Brezinski et al. 1991), was
avoided in studies II (determinants of disability) and IV (disability as a predictor of
mortality among persons with and without CHD) due to the use of random
population samples.
6.2 Methods
The validity of our findings also depended on the validity and comparability of the
measurements of disability and chronic morbidity. In the studies, self-reported
chronic diseases, clinical diagnoses, or if possible both, were used. The agreement
between health interview and health examination is substantial in assessing CVD
(Heliövaara et al. 1993). Among the participants in the field examination of the
FINRISK-97 Senior Survey, the validity of self-reported CVD was assessed by
comparing the self-reported diseases with physician-assessed clinical diagnoses.
Kappa values indicating the agreement between diagnoses from the health
interview and the clinical examination varied between 0.62 and 0.80, except for
heart failure in men (0.45).
Similarly worded standard questions relating to known diseases were used in the
surveys. Although the questions were similar, awareness of the subjects regarding
diseases diagnosed by their physicians could have changed. It might be assumed
that at the time of the later surveys individuals had used more health care and were
better informed regarding their conditions than individuals 20 years previously.
This could have resulted in an increased prevalence of reported CVDs and in a
reduction of unreported CVD-cases in the latter surveys. On the other hand, more
accurate diagnostics of some conditions may have decreased the number of false
positive disease cases (e.g. diagnostics of heart failure).
Clinical diagnoses were also used, if possible. Although similar diagnostic criteria
were used in the surveys, variations in clinical judgement can have occurred. Even
if the same physicians had performed the physical examinations 20 years apart,
diagnostic practices could have changed. Despite these possible sources of error it
is plausible that diagnostic practices in relation to CVD were fairly similar in the
different surveys. The credence that can be attached to the results in study I is
increased by the fact that both the questionnaire method and the clinical
examination method revealed almost identical changes in prevalences of CVD. The
resting ECG findings provided additional objective evidence in relation to the
results concerning CHD prevalence obtained on the basis of self-reporting and
physical examination.
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Disability was measured using similar structured questions in the surveys. The list of
functional limitations has been successfully used in a national survey to estimate the
occurrence of disability (Aromaa et al. 1989b). Most of the functional limitations
were related to rather basic ADL and IADL activities, probably not much influenced
by environmental changes during the past 20 years. The definition of disability (IV)
has been compared to physician-assessment of disability and the need for help, kappa
= 0.51 (Mäkelä et al. 1993).
Many different instruments have been used in studies of disability indicating that
there is no consensus of the best instruments for measuring disability. In this study,
the measures of disability were chosen in order to represent general and not only
CHD-specific disability at the population level. This was the main reason for not
using the NYHA-classification. However, some items from the list of functional
limitations (e.g. walking 500 m without rest, climbing a flight of stairs without
rest, and carrying a 5 kg shopping bag) are useful in assessing disability due to
CVDs. The same measure of disability was used both for middle-aged and elderly
persons. This prevented the use of more severe disability measures, yielding
extremely low prevalences among middle-aged persons. It would be useful to
examine secular changes in different degrees of disability. Due to practical
limitations it was not possible to include many different measures of disability in
these studies.
6.3 Prevalence of cardiovascular diseases (studies I and III)
6.3.1 Coronary heart disease
The prevalence of self-reported CHD in men and women aged 45–64 years had
declined significantly during the past 20 years. In women and men aged 65–74
years no significant decline occurred in the prevalence of self-reported CHD, but a
significant decline was seen in the prevalence of ischaemic ECG findings. The
decreased prevalence of ECG Q-wave changes in men suggests that the most
serious forms of CHD had also decreased. At the age 75 or over, the prevalence of
self-reported CHD increased significantly in both genders.
Previous studies on time trends in the occurrence of CHD in Finland concern
mainly CHD mortality and incidence of acute CHD events. Our results on CHD
prevalence are in line with the decreasing trend in CHD mortality and incidence of
acute CHD events (Salomaa et al. 1996a; Salomaa et al. 2003). According to a
Finnish questionnaire survey, the prevalence of self-reported CHD has declined
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among men and women aged 45–64 years (Puska et al. 1983; Piha et al. 1986;
Berg et al. 1990; Helakorpi et al. 1998; Helakorpi et al. 2002). Reports on time
trends among the elderly have been inconsistent; prevalence of CHD has declined
slightly, remained stable (Kivelä et al. 1986; Uutela et al. 1999; Sulander et al.
2001), or even increased (Kalimo et al. 1992) among persons aged 65–74 years
depending on the time period considered, definition of CHD, and gender. A study
from the municipality of Lieto, in southwestern Finland, suggests that the
prevalence of CHD decreased during the 1990s among persons aged 64–71 years
(Hartikainen et al. 2003). The age-adjusted prevalence of drug reimbursements for
CHD decreased in men and women aged 45–64 years and increased among those
aged 65 years or over in Finland from 1990 to 2003. Among those aged 75 years or
over, the prevalence doubled from 1990 to 2003 (Erityiskorvattaviin lääkkeisiin
oikeuttavat sairaudet 1986–1996; Data in files of the Social Insurance Institution,
Finland 2002) (Reunanen, personal communication).
CHD mortality and incidence of acute CHD events have decreased markedly in
Finns during the past 25 years (Salomaa et al. 1996a; Salomaa et al. 2003;
Statistics Finland 2003a). The decrease has been largest in middle-aged persons
and modest in the 65–74 age group (Statistics Finland 1996; Kesteloot et al. 2002).
More than half of the decline in mortality from ischaemic heart disease in Finland
is explained by changes in the main cardiovascular risk factors (Vartiainen et al.
1994b; Jousilahti et al. 1995). The prevalence of high BP and high serum
cholesterol concentration has declined in all adult age groups. Time trends in
smoking have also been similar across the age groups: an increase in women and a
decrease in men (Vartiainen et al. 2000; Aromaa et al. 2002). The decreases in the
prevalence of CHD in Finns aged 45–64 years can also probably be largely
explained by changes in risk factors for these diseases. In the oldest age group of
75 years or over, however, the prevalence of CHD has increased, rather than
decreased. It has been suggested that the older cohorts would carry their disease
burden until old age. The association between different cardiovascular risk factors
and subsequent CVD risk among the elderly may be different than among the
middle-aged. The association may turn out to be even opposite to that expected at
very old age (Mattila et al. 1988; Rajala et al. 1990; Hakala et al. 1997). Declining
severity of coronary events (Salomaa et al. 1995) with improvements in the
treatment of patients with coronary disease (Salomaa et al. 1999), resulting in
improved  survival of persons with CHD (Salomaa et al. 1996a; Salomaa et al.
2003), have probably contributed to the shifting of CHD occurrence towards older
age groups.
The postponement of the onset of chronic CHD may support compression of the
morbidity paradigm, which was presented in 1980 (Fries 1980). However,
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improved survival may have the opposite effect. The concept of dynamic
equilibrium proposed by Manton suggests that the severity and rate of progression
of chronic disease are related to mortality changes, so that with mortality reduction
there would also be a reduction in the rate of deterioration of the vital organ
systems of the body. This could result in more disease in the population, but at a
lower level of severity (Manton 1982). The increase in the prevalence of CHD
among persons aged 75 years or more indicates an increase in the burden caused
by CHD in this age group. The use of hospital bed days due to CHD  increased in
the 1980s, especially among the elderly and among women (Palomäki et al. 1993;
Pyörälä et al. 1994). According to the statistical database of the register of CVDs,
however, it seems that in the 1990s the increase in in-hospital days levelled off  and
a slight decrease can be observed (National Public Health Institute). The results
may indicate that a levelling off or a slight decrease in the prevalence of CHD also
occurs in the oldest old, but confirmatory evidence is needed. The hospital
discharge register is collected for administrative purposes, and thus the use of
diagnoses may vary over time. This makes it difficult to draw firm conclusions on
time trends.
There are some reports of time trends in CHD prevalence in middle-aged or elderly
persons from other countries. A Swedish study reported a decline in angina
symptom-prevalence from 1986 to 1994 for women but not for men aged 35–64
years (Glader et al. 1999). The Reykjavik study showed an increase in the
prevalence of MI but a decrease in the prevalence of AP or any manifestation of
CHD in men of 65–74 years of age from 1979 to 1987. The same study found that
in middle-aged men the prevalence of any manifestation of CHD fell from 1968 to
1986 mainly due to a marked decline in the prevalence of angina without MI
(Sigurdsson et al. 1993). Another report relating to the same study recorded an
increase in the prevalence of MI in middle-aged and especially in elderly women
from 1970 to 1990 (Jonsdottir et al. 1998). A study in the United States involving
individuals of 65 years of age or more showed no change in the prevalence of MI,
congestive heart failure, or stroke in men and women but an increase in the
prevalence of AP in men from 1971 to 1980. In women there was no change (Haan
et al. 1996). An United States study analyzing trends in the National Health
Interview Survey found that the prevalence of self-reported CHD decreased among
men and women aged 45–54 years and increased among men aged 75–84 years
from 1980 to 1989 (DeStefano et al. 1993). A study of British men suggested a
decline in the prevalence of current angina symptoms but not in the history of
diagnosed CHD from 1978 to 1996 (Lampe et al. 2001). It is difficult to draw
conclusions of time trends in different countries on the basis of these studies due to
differences in the study populations, age groups included, and definitions of CHD.
50
It may be prudent to say, however, that generally the prevalence rates have declined
in younger age groups but that changes in the elderly have varied considerably.
6.3.2 Hypertension
The results of study I suggest an increase in the prevalence of hypertension in men
and a decrease in women aged 65–74 years in Finland from 1978–1980 to 1997.
Other Finnish interview and questionnaire surveys have also shown an increase in
the prevalence of self-reported hypertension in men aged 65–74 years. The results
of these surveys are contradictory in women (Kivelä et al. 1986; Kalimo et al.
1992; Uutela et al. 1999). Comparisons of results from the Health 2000 Survey
with those from the Mini-Finland Survey (1978–1980) suggest that the prevalence
of self-reported hypertension has increased in men and women aged 30–64 and 65
or over (Aromaa et al. 2002). Statistics relating to drug reimbursement suggest an
increase in the age-adjusted prevalence of hypertension medication in men and a
slight decrease in women in the 65–74 age group from 1977 to 1996
(Erityiskorvattaviin lääkkeisiin oikeuttavat sairaudet 1977–1996). The trend in men
continued to increase slightly from 1996 to 2003, and in women the decrease
levelled off (Data in files of the Social Insurance Institution, Finland 2002)
(Reunanen, personal communication). According to the FINRISK Surveys, BP
levels in middle-aged individuals have decreased during the past 15 to 25 years
(Kastarinen et al. 1998; Vartiainen et al. 2000; Vartiainen et al. 2003). The Health
2000 Survey suggested that BP levels have decreased clearly in all age groups
(Aromaa et al. 2002).
The major reasons for the increased prevalence of reported and treated
hypertension in men are the improved treatment situation and lowering of the BP
levels used as criteria for treatment (Suomen Verenpaineyhdistys ry:n asettama
työryhmä 2002). Therefore, the apparent increase in prevalence of hypertension in
men in study I mainly reflects improved and more widely used antihypertensive
treatment.
6.3.3 Heart failure
Our results indicating a marked decrease in the prevalence of heart failure are in
line with other Finnish interview and questionnaire surveys (Kivelä et al. 1986;
Kalimo et al. 1992; Uutela et al. 1999). Comparisons of the results from the Health
2000 Survey with those from the Mini-Finland Survey also suggest a dramatic
decline in the prevalence of heart failure (Aromaa et al. 2002), and this result
corresponds well with statistics on the reimbursement of drug costs
(Erityiskorvattaviin lääkkeisiin oikeuttavat sairaudet 1977–1996). In 1999, the
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prevalence of entitlements to specially-reimbursed medication for heart failure was
5.4% in men aged 65–74 years and 4.8% in women in the same age group (Data in
files of the Social Insurance Institution, Finland 2002) (Reunanen, personal
communication). These numbers correspond well with the prevalence of clinically
diagnosed heart failure observed in our study.
One of the most important causes of this observed decrease is the improvement in
the diagnostics of heart failure. Since the early 1990s, diagnostic criteria for heart
failure are essentially based on echocardiography, whereas earlier mostly only
clinical and radiological criteria were applied. False-positive diagnoses of heart
failure were fairly common in primary health care in Finland in the 1980s (Remes
et al. 1991). The reduction in prevalence of CHD and improved treatment of
hypertension probably also contribute to the reduction in the prevalence of
clinically diagnosed heart failure.
The prevalence of clinically diagnosed heart failure has dramatically decreased in
Finland. On the other hand, it has been suggested that in some other countries the
prevalence of heart failure has increased in recent years (Cowie et al. 1997).
Studies in the United States and Scotland, based on hospitalization rates for heart
failure, demonstrate an increase in those rates and have been interpreted as
showing an increase in the prevalence of heart failure (Ghali et al. 1990;
McMurray et al. 1993). However, a population-based study from Rochester,
Minnesota, found no changes from 1981 to 1991 in the incidence of heart failure
or in survival of patients with heart failure (Senni et al. 1999).
6.3.4 Cerebrovascular disease
No secular changes were found in the prevalence of cerebrovascular disease. The
interpretation of the results is difficult due to the relatively low number of cases.
6.4 Cardiovascular diseases as determinants of disability
(Studies II and III)
Our study indicated that CVDs are important determinants of disability in Finns
65–74 years of age. In women, prior MI was a particularly strong determinant of
disability, followed by cerebrovascular diseases and heart failure. Of specific
CVDs, cerebrovascular disorder was clearly associated with disability in men.
Because CVDs were also quite common, a large percentage of disability was
attributable to CVDs in the population. Mental disorders and cognitive impairment
were even more strongly associated with disability, but these conditions were less
prevalent than CVDs in this age group.
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Other studies have also found an association between disability and CVDs among
the elderly in Finland and in other countries (Lammi et al. 1989a; Lammi et al.
1989b; Stewart et al. 1989; Guccione et al. 1994). However, there are some studies
that did not find an association between heart diseases and functional limitations
(Ahto et al. 1998; Kivinen et al. 1998; Woo et al. 1998). The lack of association
could be connected with a different heart disease pattern or the different measures
of disability employed. The varying age categories, different study designs, and
measurements of disability make the comparison of our results with other studies
difficult. Pinsky et al. found that CHD other than AP was not associated with
disability among elderly men and women, although uncomplicated and
complicated AP was associated with disability (Pinsky et al. 1990). Another study
suggested that both AP and MI may be associated with disability (Stewart et al.
1989). In our study, MI was significantly associated with disability after
controlling for other chronic disorders while AP was not. Cerebrovascular
disorders were strongly associated with disability and these results are in line with
the findings of Guccione et al. (Guccione et al. 1994). After controlling for
comorbidity, heart failure was a significant determinant of disability only in
women. Similar result was found in the study of Pinsky et al. (Pinsky et al. 1990),
possibly due to the very high prevalence of disabling CHD among those men
suffering from heart failure.
Our results supported findings from previous studies which have shown women to
have higher disability levels than men (Verbrugge et al. 1989; Andersen-Ranberg et
al. 1999). It has been suggested that men and women are not disabled by the same
conditions (Jette et al. 1988). In our study CVDs were important determinants of
disability in both genders. However, a prior MI accounted for more disability in
women than in men. In Finland there are no gender differences in in-hospital
mortality after acute MI (Schreiner et al. 2001; Salomaa et al. 2003). Prehospital
MI mortality is higher in men than in women (Salomaa et al. 2003), and it is
possible that more women than men survive with large MIs, resulting in higher
disability levels in women.
Due to the cross-sectional design of the study, the time relation of disability and
chronic diseases is not known. However, disability may also be a concurrent aspect
of a disease or disorder, and not only a consequence appearing over a long follow-
up period. The age range of our study population in study II was 65–74 years. It is
not possible to extrapolate the role of CVDs as a cause of disability among persons
aged 75 years or more on the basis of these results. The results of study III,
however, suggested that CHD remains an important determinant of disability in
women aged 75 years or more, whereas in men the importance decreases with age.
The results of study III also suggest that in women the association between CHD
and disability may be even stronger nowadays than 20 years ago. In a population
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based study from Canada, the percentage of heart diseases reported as causing
disabilities increased from 1986 to 1991 among elderly persons (Raina et al. 1998).
CHD will increasingly occur in older age groups, and as the aging of the
population continues, the number of persons with CHD may stay at the present
level or even increase. Improvements in treatment may improve the functional
ability of persons with these diseases, but they also increase the survival of persons
suffering from the most severe forms of CHD. Thus, CHD is likely to remain an
important determinant of disability in the future.
6.5 Secular changes in coronary heart disease related
disability burden (Study III)
Our findings demonstrated for the first time a simultaneous reduction of CHD and
disability in the Finnish population. A previous study also suggests that the
prevalence of disability in persons aged 65–74 years has decreased in Finland
(Martelin et al. 2002). Some other regional studies from Finland also have reported
a declining trend in disability among elderly (Jylhä et al. 1992; Pohjolainen et al.
1997; Laukkanen et al. 1999; Pitkälä et al. 2001; Sulander et al. 2001; Malmberg
et al. 2002). To my knowledge, there are no studies concerning time trends in
disability among persons with chronic CHD in Finland, or in other countries.
The prevalence of disability has decreased significantly in Finns of 45–74 years of
age over the last 20 years. The decrease was evident in men with and without CHD
and in women without CHD, but no significant decline occurred in women with
CHD.
It can be assumed that less severe CHD was better diagnosed at the time of the
latter survey than 20 years ago, and this could have increased the observed
prevalence of CHD and at the same time decreased the prevalence of disability
among persons with CHD.
The results concerning women with CHD may indicate that there are gender
differences in the nature of the disease. The results may also indicate that
improvements in therapeutic procedures have not been as effective in women as in
men; studies from Finland suggest that thrombolytic therapy was administered less
frequently to female than to male patients (Miettinen et al. 1999; Salomaa et al.
2003). On the other hand, CHD is more difficult to diagnose in women (Kwok et
al. 1999; Wenger 2002), and it may be that false positive cases of CHD were more
common in women than in men 20 years ago. The accuracy of the diagnostics of
CHD has probably improved, and as a result, the proportion of possible false
positive CHD cases may have decreased. This could partly explain why the
54
functional status of women suffering from CHD has not improved. Prevalence
changes of some other chronic disabling diseases or disorders may also partly
explain the lack of improvement in functional ability among women with CHD.
Our further analyses (data not shown) suggested that among women with CHD, the
prevalence of mental disorders and some smoking-related diseases such as chronic
bronchitis may have increased more than in women without CHD or in men.
Changes in the prevalence of CHD, and in the prevalence of disability among
persons with CHD, explained some of the change in disability among men under
the age of 75 years and among women under the age of 65 years at the population
level. These results are only rough estimates, and further studies are needed to
estimate the impact of other factors on the secular changes in disability at the
population level. There must also be other factors contributing to the change in
disability at the population level. However, studies assessing these factors are rare.
A previous study from Finland concerning persons aged 65–74 years suggested
that changes in the prevalence of CVDs and in the educational structure of the
population have contributed to the decline in the need for help from 1978–1980 to
1997 (Martelin et al. 2002).
The observed decreases in disability prevalences support the compression of
morbidity theory (Fries 1980). It seems that disability rates have decreased most
among persons under 65 years of age, moderately among those aged 65–74 years,
and least among persons aged 75 years or over. Based on these results only,
however, it is not possible to draw conclusions of the general effect of declining
disability and increasing life expectancy. If age-specific disability or morbidity
rates decline faster than age-specific mortality, then compression is established
(Fries 2003). There are some results from Finland suggesting that disability-free
life expectancy  at age 65 has increased and years lived with disability have
decreased during the past 20 years (Sihvonen et al. 2003). Information from other
countries also suggests that increased life expectancy is not accompanied by an
increase in the time lived with severe disability. Results including also milder
disability are diverse. Comparisons between countries are difficult due to
differences in the characteristics of national health surveys with regard to protocol
or question formulation (Robine et al. 1999).
Our study provides a clear picture of the effect of declining mortality and
incidence of acute CHD events on the prevalence of the disease, demonstrating a
decrease in the prevalence of CHD among the middle-aged and an increase among
men and women aged 75 years or over during the past 20 years in Finland.
Improvements in treatment may improve the functional ability of persons with
these diseases, but they probably also increase the survival of persons suffering
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from the most severe forms of these diseases. Our results concerning the
remarkable role of CVDs (especially MI in women) as determinants of disability in
the elderly, and results suggesting an increase in the prevalence of CHD among
persons aged 75 years or more, suggest an increase in the CHD-related disability
burden among the elderly. The burden caused by CHD has not disappeared, but it
has shifted to older ages. Adequate care and rehabilitation of elderly persons
suffering from these diseases is important. A recent study from Helsinki University
Hospital reported that elderly acute MI patients did not receive the same standard
of treatment and prevention as younger patients, and the in-hospital mortality was
high (Kotamäki et al. 2003). A multifactorial cardiovascular disease prevention
study among home-dwelling CVD patients aged 75 years or more aims to clarify
whether it is possible to treat the elderly in the real world according to established
guidelines and whether this confers clinical benefits (Strandberg et al. 2001a). An
American Heart Association Scientific Statement recently called for greater use of
secondary preventive therapies in the elderly (Williams et al. 2002). The care of
elderly patients, especially elderly women, with CHD, will have important
implications on the public health burden.
Good health and functional capacity at old age is a consequence of good health and
good care of risk factors and chronic diseases at young and middle ages. Effects of
good health habits on subsequent disability are considerable (Vita et al. 1998).
Low cardiovascular risk in middle age is associated with lower mortality,
morbidity, and better quality of life in old age (Strandberg et al. 2004). Active
interventions to reduce risk factors should begin at young adulthood or midlife.
The recent increase in the prevalence of obesity among young and middle-aged
Finns (Lahti-Koski et al. 2001; Vartiainen et al. 2003; Männistö et al. 2004) and
the estimated rising burden of diabetes (Amos et al. 1997; King et al. 1998;
Reunanen 2003) may increase CVDs and subsequent disability among the elderly
in the future.  Elderly persons in better health had longer life-expectancy than
those in poorer health, but they did not have higher health care expenditures. Thus,
health-promotion  efforts under the age of 65 years may improve the health and
longevity without increasing health expenditures (Lubitz et al. 2003).
6.6 Disability as a predictor of mortality (Study IV)
In this prospective, population-based study, general disability at baseline was
associated with a substantial increase in mortality from CHD and all-causes in
middle-aged and younger elderly men with CHD, but the association in women
with CHD was not statistically significant. Disability was also associated with
excess mortality risk in both men and women with no CHD at baseline.
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Our results are in line with studies from acute clinical settings (Brezinski et al.
1991; Vaccarino et al. 1997; Spertus et al. 2002). However, our results can be
generalized to all CHD patients in Finland. Our findings suggest that the
association between disability and all-cause and CHD mortality may be stronger in
men than in women with CHD. A previous study by Vaccarino et al. also suggested
that disability was more strongly associated with mortality in men with MI than in
women (Vaccarino et al. 1997). Corti et al. found physical disability to double the
risk of CHD mortality among elderly men and women in a population based study.
However, they did not examine the association between disability and mortality in
persons with baseline CHD (Corti et al. 1996).
The differences between men and women in our results may reflect a gender
difference in the nature of CHD and also the differing aetiology of disability
between men and women. CHD manifestations differ by gender: acute MI and
sudden death are the most usual manifestations in men, whereas AP is the most
common manifestation in women (Reunanen et al. 1983). Women with AP have a
more favourable outlook than men with similar symptoms (Murabito et al. 1993).
AP symptoms obtained using the WHO questionnaire did not predict future
mortality in women in a Finnish prospective population study, whereas in men they
were strong predictors of mortality (Reunanen et al. 1983). This may imply that
many women with AP symptoms actually suffer from chest pain due to causes
other than CHD. In the present study, the proportion of subjects with previous MI
among those with CHD at baseline was higher in men than in women, indicating
that CHD was more severe in men than in women. CHD in women may be less
disabling, and a higher proportion of disability in women than in men may be due
to other, possibly less lethal, causes than CHD. Moreover, disability in women may
be different from that in men; men may be more reluctant to report difficulties in
ADL than women. In addition, the numbers of cases and deaths were smallest in
women with CHD, which may reduce the strength of this interpretation.
The end-point examined in this study was mortality. It should be kept in mind,
however, that mortality is not the only measure of suffering and poor prognosis.
Based on these results, it is not possible to estimate the impact of disability on
future need for help or quality of life, which would be important.
Disability is an excellent marker for the overall burden and severity of disease in
older persons, and thus a strong predictor of mortality (Guralnik et al. 1996; Scott
et al. 1997; Inouye et al. 1998; Ostbye et al. 1999). On the other hand, it has been
reported that objective CHD severity has only a fairly weak connection with self-
reported functional status (Sullivan et al. 1996). Activity limitations are also
determined by many factors that are not causally associated with increased
mortality risk. The measure of disability used in this study was chosen to represent
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general and not only CHD-specific disability, and this was the main reason for not
using physician-assessed physical functioning (e.g. NYHA-classification).
In middle-aged and younger elderly men, general disability identifies a group at
high risk of death from CHD or all-causes. Disability did not predict mortality in
the age group of 75 years or more. Among the elderly mortality is possibly
determined by factors different from those at younger age. Cardiac rehabilitation is
associated with improved outcomes, including reduced mortality and improve-
ments in physical functioning after a cardiac event, regardless of age (Ades et al.
1999; Pasquali et al. 2001). The goals of rehabilitation of older coronary patients
are to improve physical functioning and quality of life and to extend disability-free
survival (Ades 1999). Interventions that successfully improve physical function in
the expanding elderly population with CHD will have important public health
implications.
6.7 Implications for future research
Due to positive changes in cardiovascular risk factors and improved treatment of
acute MI and chronic CHD, mortality, incidence, and prognosis of CHD have
improved. As a result of these changes prevalence of CHD has also declined
among working-aged Finns. Among persons aged 75 years or more, however, the
prevalence of CHD has increased. CHD will increasingly occur in older age
groups, and as the aging of the population continues, the number of persons with
CHD may increase.
Changing diagnostic and treatment practices are important in determining the
health care burden at a given level of incidence and prevalence of the disease.
Consequent disability determines the burden on social services. Better treatment
may improve the functional ability of persons with CHD, but it also increases the
survival of persons suffering from the most severe forms of the disease. As the
population suffering from CHD becomes older, their functional ability becomes
more important. It is important to understand the needs of secondary prevention,
treatment, and rehabilitation of these elderly CHD patients in order to maintain and
improve their functional capacity.
Successful CVD prevention has had a positive effect on functional capacity at the
population level. The contribution of secular changes in prevalence and severity of
other somatic and mental chronic conditions to different levels of population
disability should be examined.
Besides chronic diseases and their treatment, many other factors also determine the
functional capacity of the elderly, including many personal, lifestyle, psychosocial,
socioeconomic, societal, and environmental factors. Many of these stem from
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earlier phases of life. Future research should reveal those modifiable factors which
contribute to good functional capacity in older ages. Environmental risk factors
have not been properly investigated; changes in the environment also contribute to
good physical functioning. Additional research is needed for the development of
effective interventions in order to improve the functional capacity of elderly
persons. Continuous evaluation of population health, functional status, and the
need for help is required for improving the assessment of these conditions and
evaluating interventions at population level.
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SUMMARY AND CONCLUSIONS
Prevalence of CHD has decreased in men and women aged 45–64 years, decreased
slightly, but not significantly, in the 65–74 age group, and increased significantly
among men and women aged 75 years or over in Finland during the past 20 years.
The decreased prevalence of ECG Q-wave changes in men aged 65–74 years
suggests that in particular the most serious forms of CHD has decreased among
them.
Prevalence of clinically diagnosed heart failure decreased substantially in men and
women aged 65–74 years. One of the most important causes of this was the
reduction in false positive heart failure diagnoses due to improvements in the
diagnostics of heart failure over past 20 years. The reduction in prevalence of CHD
and improved treatment of hypertension probably also contributed to the reduction
in the prevalence of heart failure. Prevalence of hypertension increased in men and
decreased in women aged 65–74 years. The apparent increase in men was mainly
due to improved and more widely used antihypertensive treatment.
CVDs are important determinants of disability among Finns aged 65–74 years. In
men, a third and in women a fourth of disability was attributable to CVD,
excluding hypertension alone. Of specific CVDs, cerebrovascular diseases, and in
women also MI and heart failure, were the most important determinants of
disability. A prior MI in women was even more strongly associated with disability
than heart failure and cerebrovascular disorders.
Functional ability has improved in Finns up to 74 years of age over the past 20
years. The decrease in disability was observed in men with and without CHD and
in women without CHD, but in women with CHD the decrease was not statistically
significant. During the past 20 years in Finland, the decreased prevalence of CHD
together with changes in functional ability among persons with CHD explained a
fifth of the improvement in functional capacity in men aged 45–64 years, a fourth
in men aged 65–74 years, and 17% in women aged 45–64 years. However, in men
aged 75 years or over and in women aged 65 years or over, the CHD-related
disability-burden tended to increase. The burden caused by CHD has not
disappeared, but it has shifted to older ages. In particular, elderly women with
CHD need more attention in order to prevent the burden caused by CHD and its
consequences to increase.
Disability predicted mortality from CHD and all-causes in men with and without
baseline CHD, and in women without CHD. In women with CHD, disability seemed
not to be related to excess mortality. This may reflect a gender difference in the
nature of CHD, and also a differing aetiology of disability between men and women,
but these findings need to be verified in other large-scale population studies.
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